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The inherited disease galactosaemia is caused by a deficiency 
of galactose-l-phosphate uridyl transferase. A related 
clinically serious disorder caused by a deficiency of uridine 
diphosphate galactose 4' epimerase has now been found and an 
animal model produced in CHO cells. Completely epimerase 
deficient cells would be unable to synthesise the galactose 
required for important structural components.
This thesis investigates the effect on cultured cells of these 
disorders of galactose metabolism, including whether epimerase 
deficient cells need galactose supplementation for normal 
growth.
Four classes of experiment were carried out:
1) Galactose content of culture media. It was necessary to 
establish rigorously the conditions in which cells were 
cultured. Analysis showed no measurable free galactose in the 
culture medium, but the presence of glycoproteins with exposed 
galactosyl residues was demonstrated.
2) Cell growth in normal media. Epimerase deficient 
fibroblasts and CHO cells did not require galactose 
supplementation for growth. Transferase deficient cells took 
up significantly more uridine and thymidine, demonstrating 
important abnormalities in purine and pyrimidine metabolism.
3) Growth in media supplemented with galactose. Control cell 
lines increased in number, transferase deficient lines 
initially increased then decreased, showing a delayed toxic 
effect, and epimerase deficient cells steadily decreased.
4) Galactose content of cells. Western blotting and staining 
with galactose specific lectin both showed that galactose was 
present in epimerase deficient fibroblasts and CHO cells. Gas 
chromatography of hydrolysed cell carbohydrates confirmed this 
and showed that transferase deficient cells have significantly 
less galactose in their glycoproteins.
Conclusions r Epimerase deficient human fibroblasts grew 
adequately without added galactose, and contained normal 
amounts of galactose produced either from residual enzyme 
activity or from galactoproteins in culture media. Epimerase 
deficient human subjects are therefore unlikely to require oral 
galactose supplementation. Transferase deficient fibroblasts 
had an abnormal pattern of glycosylation, which is likely to be 
related to the long-term pathogenesis of this condition in 
humans.
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In 1980 a new inherited disorder of galactose metabolism was 
identified at Southmead Hospital, Bristol. The discovery of 
this galactose intolerant, epimerase deficient patient raised 
questions about the effects of dietary galactose in this 
condition, in particular whether the deficiency was complete 
in which case galactose supplemetation would be required for 
normal growth. In this research project, cultured cell 
fibroblasts have been used as a model to study the requirement 
of these cells for galactose, and its toxic effects upon them. 
Lectins have been used in this work to investigate the 
presence and structure of complex galactosides in epimerase 
deficient cells. Accordingly this introduction is concerned 
with galactose metabolism and its disorders, with cell culture 
and its use in the investigation of inherited diseases, and 
with the use of lectins in the study of galactose containing 
glycoproteins.
Section 1: Galactose
1.1.1 Galactose: history and occurence
Galactose is a monosaccharide, the carbon 4 epimer of glucose. 
It was discovered in 1856 by Pasteur as a constituent of milk 
sugar or lactose, the disaccharide of glucose and galactose. 
Most galactose in the diet is in the form of lactose, which is 
the main carbohydrate source for nursing mammals and provides 
40% of the energy in human milk. However galactose is more 
than simply an energy source for conversion into glucose, it 
is also an important structural component of cells, 
particularly the specific antigenic determinants of cell
3surfaces. It is clear that although most galactose consumed is 
converted to glucose, the rest plays a role for which no other 
monosaccharide may be directly substituted.
1.1.2 Galactose as a Structural Component 
Besides existing in vivo as glycogen or blood glucose, 
carbohydrates are present as part of glycoproteins or 
glycolipids. Some glycoproteins contain oligosaccharides 
attached to a protein core, for example fibrinogen, the blood 
group substances and immunoglobulins. Others contain much 
longer polysaccharides combined with protein, such as the 
mucopolysaccharides hyaluronic acid, chondroitin sulphates, 
heparin keratan sulphate and dermatan sulphate. Larger 
carbohydrates are generally building blocks - they are present 
for their structural function. In contrast the function of 
glycoproteins that contain oligosaccharides is related to 
molecule or cell recognition, hence their occurance in 
immunoglobulins and blood groups. For instance blood group B 
substance is converted to H substance by removing the terminal 
D-galactose residues. Whether present for their structural or 
recognition roles it is apparent that any changes in the shape 
of a carbohydrate would impair or destroy the ability of that 
glycoprotein to function. Monosaccharides such as the epimers 
glucose and galactose differ only in shape rather than 
composition. It is clear that a correct balance of exactly 
the right monosacchrides is required to produce a normally 
functioning glycoprotein.
The number of carbohydrate groups attached to each protein 
ranges from one in ribonuclease B to very many in the mucins, 
and the proportion of carbohydrate varies from less than 1% in
4collagen to 80% in blood group substances and almost 100% in
the mucopolysaccharides. Galactose or N-acetyl galactosamine
form a large proportion of the carbohydrates in many
glycoproteins, for example it forms the majority of the
carbohydrates in the repeating unit of chondroitin 4-sulphate,
found in cartilage, skin and bone:
4 )-0-D-GlcA-( l-»3 )-0-D-GalNAc 4-sulphate-(l->
and blood group B-substances:
Gal-r( l->3 )-Gal-0( l->3 )-GlcNAc-|3( l->3 )Gal-»
T
Fuc y(l-»2)
In synthesising glycoproteins the donors of the sugar units 
are the nucleotide diphosphate sugars. The first 
transylucolase is specific for the amino acid residue to 
which the sugar will be linked, and all transglycolases are 
specific for the sugar donated, and to varying degrees are 
specific for the acceptor sugar unit. Unlike protein 
synthesis there is no structural template, and control is 
exercised by the specificities of the transglycolases and 
also the levels of the nucleotide phosphate sugar donors.
The sialic acids are a ubiquitous family of sugars found in 
glycoproteins and glycolipids and are derivatives of 
neuraminic acid. They appear to act as terminators of 
further glycosylation when attached to terminal sugars. The 
sugar to which they are bound is almost always galactose.
In glycolipids carbohydrates play a similarly important 
structural role and once again galactose is a frequent 
component. A common example is galactosyldiacylglycerol 
which is a major constituent of myelin and other neural 
tissue.
51.1.3 Galactose Metabolism
Quantitatively the principal fate of ingested galactose is 
consumption as an energy source. Since it cannot be used 
directly the main pathways of galactose metabolism bring 
about its coversion to glucose. Exactly how galactose is 
used as an energy source was not known until the early 
1950's, nearly a century after its discovery. In a number 
of important papers Leloir (1951) and Kalkar (1953) described 
the principal pathway of galactose metabolism in humans. That 
pathway now bears Leloir's name.
The Leloir Pathway
This allows the conversion of galactose to glucose by 
epimerisation of the carbon 4 hydroxyl group. Only uridine 
dinucleotide derivatives of these sugars are suitable 
substrates for epimerisation hence several enzymatic steps 
are required for the interchange. The pathway is shown in 
below:
1
galactose -> galactose-l-phosphate glucose-l-phosphate




2: Galactose-l-phosphate uridyl transferase
3: UDPglucose UDPgalactose epimerase
The Enzymes of the Leloir Pathway
The Enzymes of the Leloir Pathway
Galactokinase EC 2.7.1.6: Galactose -» Galactose-l-phosphate
The first evidence for the existence of this enzymes came in 
1943 with the isolation of galactose-l-phosphate from the 
liver of rabbits fed on high doses of galactose (Kosterlitz 
1943). The enzyme has now been investigated in yeast and 
bacteria (Caputio 1948 and Sherman 1963) and a wide range of 
mammalian tissues including rat and pig liver, and human 
liver, erythrocytes, fibroblasts and placenta (Ng 1965,
Chacko 1972, Srivastava 1972). The human erythrocyte kinase 
has been shown to have a dimeric structure with each 
component of molecular weight about 26000 (Blume and Beutler 
1971). All forms of galactokinase (kinase) so far discovered 
need ATP as a cofactor and require magnesium ions for 
activity (Atkinson 1961). The reaction is reversible, but 
equilibrium lies far to the side of galactose-l-phosphate 
(gal-l-P). High concentrations of both galactose and gal-l-P 
have been found to inhibit the enzyme in human tissues 
(Mathai and Beutler 1967), a property that would tend to 
prevent the formation of excessive amounts of gal-l-P. In the 
human foetus activity can be detected as early as seven weeks 
gestation and increases until term (Shin-Beuring 1977).
Kinase activity in the red cells of new born infants is about 
three times that of adults (Ng et al 1965) and there is 
evidence of racial polymorphism (Tedesco 1972a). In humans 
the kinase locus is on chromosome 17 q21 q22.
Galactose-l-phosphate uridyl transferase EC 2.7.7.12 
Gal-l-P ----- -> UDPgal
7Discovered in 1951 by Leloir, galactose-l-phosphate uridyl 
transferase (transferase) catalyses the second step of the 
pathway. It has now been widely investigated in its 
structure, mechanism, kinetics and genetics. The enzyme has 
been found in bacteria, yeast and most mammalian tissue. The 
bacterial enzyme consist of two subunits, each of 40000 
Daltons and the yeast enzyme is also a dimer, of 86000 total 
molecular weight (Saito 1967, Segawa and Fukasawa 1979). The 
most extensive studies have been on the human red cell enzyme 
but opinion differs as to its size and structure. Tedesco 
(1972b) using gel filtration and SDS Page proposed a trimeric 
structure of 90000 Daltons whereas Dale and Popjack (1976) 
after including uridine aminohexyl affinity chromatography 
produced a higher specific activity enzyme preparation with a 
molecular weight of 69000.
Williams (1978) proposed a dimeric enzyme, of 88000 Daltons 
total molecular weight by SDS Page but 67000 by gel 
electrophoresis. Isoelectric focusing of human liver 
transferase on acrylamide gel showed several bands of 
activity, suggesting a degree of heterogeneity (Schapira 
1978). As with kinase, transferase activity is present in 
foetal liver, activity being highest at 25 weeks gestation. 
There is no change in Km during gestation, making a foetal 
form of the enzyme unlikely (Shin Buehring 1977). 
Glucose-l-phosphate has been shown to be a potent inhibitor 
of transferase and uridine mono-, di- and tri-phosphates are 
powerful competitors of the substrate UDP-glc which itself 
displays inhibition at higher concentrations (Forster 1975a). 
From the calculated intracellular levels of these substances
8it seems that the rate of reaction is regulated by substrate 
concentration. The inhibition by glucose-l-phosphate may 
explain the observation that transferase activity has been 
shown to be influenced by the state of carbohydrate 
metabolism. Perfusion of suckling rat liver with either 
glucose or galactose induces a rise in transferase activity 
initially but this falls to low levels after 90 minutes 
(Rogers 1981). Perhaps the fall results from an accumulation 
of glucose-l-phosphate, but the mechanism of the rise is not 
known.
The mechanism of the reaction has been investigated in 
bacteria and humans and found to be the same (Marcus 1977). 
It is of the ping pong type and is shown in the following 
steps, where E denotes the transferase enzyme:
E + UDPglc -* UDPglc-E -» UMP-E-glclP -» UMP-E + glc-l-P
UMP-E + gal-l-P -> UMP-E-gal-l-P + UDPgal-E -> UDPgal + E
The kinetics and mechanism of the E coli and human forms of 
the enzyme are the same, suggesting that selective 
determinants have produced a convergence of characteristics 
in these two phylogenetically widely separated species.
Uridine-5-Diphosphogalactose-4-Epimerase (E.C. 5.1.3.2)
UDPglc ----> UDPgal
This enzyme and the consequences of its absence from living 
tissues are the main subject of this work; accordingly it 
will be considered in rather more detail than the other
9enzymes of the Leloir pathway. Epimerase catalyses the step 
at which galactose and glucose are interconveted by inversion 
of the hydroxyl group at carbon 4. This allows the catabolism 
of galactose as an energy source or the synthesis from 
glucose of galactosides, since UDPgal is the galactosyl donor 
for galactoside synthesis. There is also evidence that the 
same enzyme is responsible for the conversion of the N-acetyl 
derivatives of these sugars, ie for the reaction
UDP N-acetyl glucosamine -» UDP N-acetyl galactosamine. 
Epimerase activity has been found in a range of organisms and 
tissues, including yeasts (Darrow 1966 and 1970), bacteria 
(Wilson 1964 and 1969), mammalian liver (Cohn 1969, Geren 
1977), human fibroblasts (Chacko 1972) and human erythrocytes 
(Bergren 1973).
NAD has an important association with epimerase. It is a 
cofactor for all forms of the enzyme, whilst NADH may inhibit 
the reaction (Maxwell 1957). Epimerase from yeast and E. coli 
contains one mole of NAD for each of enzyme. The cofactor is 
inactive in its reduced form and is retained tenaciously by 
the enzyme (Maxwell 1960). Yeast epimerase is not inhibited 
by exogenous NADH.
Human erythrocyte epimerase
Lysates of adult human erythrocytes show epimerase activity 
only on addition of exogenous N A ^ )  however neonatal 
erythrocytes do not require any added NAD (Ng 1967). Bergren 
(1973) showed that adult red cells contain significant 
amounts of NAD whereas their haemolysates do not. In 
neonatal erythrocytes however the levels are similar before 
and after lysis. It would seem that in adult's erythrocytes
10
intracellular NAD is destroyed during lysis by the activity 
of a stromal NAD nucleosidase, which is not present in 
neonates.
Starch gel electrophoresis of neonatal red cell lysates 
showed two bands of epimerase activity whereas adult 
erythrocyte lysates showed only one band. The addition of NAD 
to adult lysates produced two bands on electrophoresis 
identical to those of neonates, suggesting an NAD dependant 
structural change in the enzyme.
Cultured cell epimerase
The enzyme in cultured human fibroblasts has been 
characterised and cannot be induced by the addition of 
galactose to the cell culture medium. In cultured fibroblasts 
as with red cells the ratio of NAD to NADH affects epimerase 
activity. HeLa and L cells both show epimerase activity if 
NAD is added. Without the addition of NAD the cells show 
little activity though this can be increased by the addition 
of pyruvate (Robinson 1963). The enzyme optimum is pH 8.7 but 
at physiological pH the NADH inhibition was found to be more 
pronounced than at pH 8.7. Low enzyme activity in cultured 
cells may therefore be due to high NADH/NAD ratios and low pH 
resulting from anaerobic glycolysis during culture.
1.1.4 Other Pathways of Galactose Metabolism 
Uridine Diphosphogalactose Pyrophosphorylase
Gal-l-P + UTP ------- -> UDPgal + PP
The enzyme catalysing this reaction was first described in 
yeast (Kalkar 1953) and then found in mammalian liver 
(Isslebacher 1957,1958). The human liver enzyme has been
purified and shown to be inhibited by UTP (Abraham 1969). 
However, when the lack of specificity of UDPglucose 
pyrophosphorylase became known (Lee 1978), doubt was cast 
upon the existence of a separate enzyme for galactose. There 
is now considerable evidence that the activity found is 
simply due to the non-specific action of UDPglucose 
pyrophosphorylase (Knop 1970 Chacko 1972). For instance the 
ratio of activity of UDPglc pyrophosphorylase to UDPgal 
pyrophosphorylase remains constant throughout purification, 
and UDPglc limits the synthesis of gal-l-P from UDPglc by 
haemolysates. The existence of a separate pyrophosphorylase 
for galactose is therefore not clear.
Reduction to Galactitol
Reduction of sugars to polyols was first described by Hers in 
in the seminal vesicles and placenta of sheep (1960). 
Galactitol has been found in the tissue and urine of humans 
but reduction via this pathway only occurs to any significant 
extent when tissue levels of galactose are very high and 
normal metabolism is blocked (Moonsammy 1967). Two enzymes 
can bring about this change: one is aldose reductase or 
polyol: NADP oxidoreductase, which acts on a number of 
aldehydes, principally glyceraldehyde (Hayman 1965,66). The 
other enzyme is L-hexonate dehydrogenase whose preferred 
substrates are uronic acid and its lactones (Nano 1961). It 
does act on galactose, but with much less affinity than 
aldose reductase. Both these pathways are only important 
when tissue levels of galactose are high, however this can be 
particularly consequential in the lens of the eye, which can 
be damaged by high levels of galactitol.
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Oxidation via Galactonate
Galactose --------- ► Galactonic acid
I
D-Xylulose <------------ Beta-keto galactonic acid
Dehydrogenation of the aldehyde at carbon one of galactose 
forms galactonic acid. This is the first step of an oxidative 
pathway of galactose metabolism described by Cuatrecacas and 
Segal (1966). They characterised the enzyme galactose 
dehydrogenase and proposed it as the first step of the 
pathway shown above, to form D-xylulose, a sugar capable of 
further metabolism. However, Srivista (1969) failed to 
demonstrate the oxidation of galactose to galactonate but did 
give evidence for the formation of galactose-6-phosphate and 
its subsequent oxidation to 6-phosphogalactonic acid. 
Galactonate is excreted in the urine of humans whose normal 
pathways of galactose metabolism are blocked (Bergren 1972).
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Section 2: Disorders of Galactose Metabolism
1.2.1 History
The first detailed report of a disease involving galactose 
metabolism was by Goppert (1917). He described a two year old 
child who had an enlarged liver, delayed mental and physical 
development, and galactose and albumin in his urine. This 
child had severe icterus until 8 months of age. Goppert found 
that putting the child on a milk free diet caused him to 
improve markedly: the liver reduced in size, sugar and albumin 
disappeared from the child's urine and his mental and physical 
development improved.
The term galactosaemia is now used to describe the inherited 
disoders caused by the absence of an enzyme required for 
galactose metabolism. Lesions have been found at the level of 
transferase, kinase and epimerase. These all result in 
elevated levels of galactose in the blood, ie galactosaemia. 
The term should therefore be qualified by mention of the 
missing enzyme. Goppert's case was most probably transferase 
deficiency galactosaemia.
1.2.2 Galactokinase deficiency
This defect was first described in a blind 44 year old Swiss 
gypsy by Gitzelman in 1965. The subject had recurrent 
cataracts and mellituria as a child. He was investigated by 
Fanconi at that time who identified the sugar in the childs 
urine as galactose and termed the condition galactose 
diabetes. Thirty-five years later Gitzelmann showed that the 
same subject lacked erythrocyte galactokinase and that his 
conversion of radiolabelled galactose to carbon dioxide in
14
vivo was minimal, suggesting that the enzyme was missing from 
all tissues.
The only clinical symptom of the deficiency is the occasional
occurrence of cataracts. Deficient subjects show no aversion
to galactose or lactose and it is noticeable that the kidney
and liver damage and mental retardation of transferase
deficiency do not occur. Treatment is by the exclusion of
galactose from the diet. This is advised in order to inhibit
the formation of cataracts. Studies in Gitzelmann's subjects
showed that ingested galactose was excreted as galactose and
galactitol in the molar ratio of about 4:1 (1974). Only about
5% of labelled galactose activity appeared in expired air, an
amount similar to that produced by transferase deficient
galactosaemics, probably by the decarboxylation of galactonic
0>rt
acid. Since epimerase and pyrophosphorylase^functioning 
kinase deficient subjects should be able to synthesise 
sufficient galactose for developmental requirements from 
glucose while they are on a galactose free diet.
The disorder is transmitted by autosomal recessive 
inheritance. Population studies have shown a heterozygote 
frequency of about 1% which would give a birth incidence of 1 
in 40000 (Gitzelmann 1967). However, the observed incidence 
in Germany and Austria was found to be only about 1 in 155000 
(Gitzelmann 1980). No doubt this discrepancy is in part due 
to some cases being missed, but genetic heterogeneity may , 
contribute: the first four cases found were unrelated gypsies 
so it is possible that this group has a higher incidence of 
carriage of the gene for kinase deficiency.
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1.2.3 Hereditary transferase deficiency
This is the most common disorder of galactose metabolism and 
the one which has been the most extensively investigated. 
Although galactosaemia was recognised as a disorder from the 
early part of the century, the location of the enzyme defect 
was not discovered until much later. In 1956 Schwarz found 
elevated levels of gal-l-P in the erythrocytes of patients 
with galactosaemia. This led Isslebacher (1956) to assay the 
enzymes of the Leloir pathway and show that red blood cells 
from galactosaemics specifically lacked transferase. The 
deficiency has now been shown to exist in cultured 
fibroblasts, amniotic fluid cells and in leucocytes and liver 
tissue. Transferase deficiency is transmitted as an autosomal 
recessive trait and heterozygotes for the galactosaemia gene 
have about half normal activity.
Affected children usually present in the neonatal period. They 
have normal birth weights but gain little after they start 
milk feeds. Symptoms usually appear in the second half of the 
first week of life, and include jaundice, vomiting, lethargy, 
aminoaciduria, galactosuria and cataracts. If a 
galactose-free diet is instituted symptoms resolve promptly. 
However some degree of irreversible brain damage may occur.
The average IQ of a group of British galactosaemics was 80, 
and was found to decrease with age. However galactosaemics in 
whom intrauterine exposure to galactose was kept to a minimum 
by restriction of the maternal diet were found to have 
virtually normal distribution of IQ's (Fischler 1980). 
Treatment with a galactose free diet can be monitored by 
measurment of erythrocyte gal-l-P.
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1.2.4 Galactose metabolism in transferase deficiency
Initial investigations were carried out in vivo in 
galactosaemic subjects to establish whether they could 
metabolise galactose at all, and if so by which pathways. In 
a group of 14 galactosaemics, nine showed between 0 and 8% 
conversion of labelled galactose to CO2 and five, all black 
had near normal rates (Segal 1968). The poor converters were 
all Caucasians and did not improve their ability to metabolise 
galactose when monitored over several years. Biopsies of 
liver and intestinal mucosa from black subjects showed about 
10% of normal activity. It was concluded that black subjects 
have some capacity to oxidise galactose because of residual 
activity in their visceral tissues. That they showed clinical
features of galactose toxicity in the neonatal period may be
due to the large amount of galactose ingested then. 
Accumulation of gal-l-P in galactosaemics is probably not 
exclusively due to the phosphorylation of galactose by kinase. 
In both normal and transferase deficient subjects it may be 
formed by the action of epimerase and pyrophosphorylase:
epimerase 
U D P g l c ----------> UDPgal
pyrophosphorylase 
UDPgal + PP -------------------> gal-l-P + UTP
There is considerable evidence that gal-l-P is formed in
galactosaemics by this pathway. Tranferase deficient 
fibroblasts accumulate gal-l-P in a galactose free medium
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(Pourci 1990). One newborn galactosaemic was given parenteral 
nutrition only for his first 24hr,' however his erythrocyte 
gal-l-P rose over this period (Gitzelman 1975). Transferase 
deficient newborns have raised gal-l-P even though their 
mothers abstain from galactose during pregnancy. However 
experiments with labelled galactose show a different yield of 
CO2 when carbon-1 or carbon-2 labelled galactose is given: 
this is consistent with direct oxidation to galactonate 
followed by decarboxylation. No difference would be found if 
oxidation occured via pyrophosphorylase. Therefore it seems 
that the pyrophosphorylase pathway can contribute to the 
formation of gal-l-P but not its breakdown which is 
surprising. The true importance of this pathway in 
galactosaemia has probably yet to be established.
One pathway that is clearly functioning is reduction of 
galactose to galactitol by aldose reductase, an NADPH 
requiring enzyme with a broad specificity for aldehydes. 
Galactitol has been found in the tissue and urine of 
galactosaemics and was shown to be formed from labelled 
galactose (Quan-ma 1966). Galactitol is not further 
metabolised, the main route of elimination being excretion in 
the urine. This continues for several days after galactosuria 
has stopped.
1.2.5 Incidence of transferase deficiency 
Transferase deficiency galactosaemia is transmitted as an 
autosomal recessive trait. Heterozygotes for the galactosaemia 
gene have about half normal activity. Several studies have 
investigated the incidence of transferase deficiency in a
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number of areas, either from the results of neonatal screening 
or the detection of heterozygotes. Six million newborns have 
been screened worldwide with a detection rate of 1 in 62000 
(Levy 1980). Estimates based on the detection of 
heterozygotes in Wales, Denmark and the United States gave 
figures ranging from 1 in 18000 to 1 in 180000. The observed 
prevelance at birth was 1 in 70000 (Schwarz 1961). Various 
factors could account for this range of figures. These could 
include heterogenious distibution of the enzyme between 
various populations, differences in the effectiveness of 
screening programmes and errors resulting from small sample 
size. Prevalence at birth will give an underestimate in the 
likely event of some cases being missed.
1.2.6 Transferase polymorphism
In 1966 Beutler described the Duarte variant of transferase 
which has reduced activity in red cells and other tissues. 
Heterozygotes have about 75% of normal activity and 
homozygotes 50%. The Duarte variant is indistinguishable by 
Michaelis constant, pH optimum or thermal stability but it 
migrates faster on starch gel electrophoresis (Beutler 1966). 
The most common cause of an abnormal result in galactosaemia 
screening is double heterozygosity for galactoaemia and the 
Duarte variant. Schwarz (1982) found that challenging these 
subjects with a galactose load resulted in raised levels of 
blood galactose and gal-l-P. They suggest that such a marked 
abnormality in the ability of these subject to metabolise 
galactose raises questions about the appropriate dietary 
recomendations for them.
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A number of other variants have now been described and all 
except the Los Angeles variant have lower activity than the 
wild type. In combination with the gene for classical 
galactosaemia most variants can produce moderate symptoms such 
as raised blood galactose and galactosuria. The Indiana 
variant was described in an 18 month old Caucasian girl who 
had galactosuria and raised red cell gal-l-P and blood 
galactose when challenged with milk (Chako 1971). Her 
erythrocyte activity was about 35% of normal, but was highly 
unstable and could not be detected on electrophoresis. An 
elder sib of this case had died at six weeks with symptoms of 
galactosaemia.
1.2.7 Epimerase Deficiency
Epimerase is the only known enzyme which actually 
interconverts glucose and galactose in any form. A deficiency 
was thought to be incompatable with life (Kalkar 1965). The 
absence of epimerase in any organism would produce a galactose 
auxotroph, ie one that would require dietary galactose for the 
synthesis of galactosides from UDPgal. It would also be 
unable to dispose of ingested galactose by converting it to 
glucose.
However Gitzelman reported nine individuals whom he described 
as being epimerase deficient (1980). Five were discovered on 
neonatal screening for galactosaemia and the other four were 
relatives of the affected neonates. All subjects were 
asymptomatic and needed no dietary restriction of galactose. 
The only abnormality in these cases was raised erythrocyte 
gal-l-P which was responsible for the positive screening
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tests. The condition seemed to be benign because
the defect was restricted to circulating erythrocytes and
leucocytes.
In all cases where epimerase activity was measured in liver or 
fibroblasts at least 50% of normal activity was found. The 
condition was transmitted as an autosomal recessive trait.
The incidence is hard to estimate because of the lack of 
symptoms, but the Swiss study showed an incidence of 1 in 
46000.
Then Holton et al (1981) reported a severly ill baby girl with 
symptoms similar to transferase deficiency galactosaemia but 
with normal transferase activity. This child was found to be 
deficient in erythrocyte epimerase, and subsequently also in 
cultured fibroblast epimerase (Gillett 1983). Further work on 
this index case by Gillett (1985) suggested that this subject 
did possess some epimerase activity: about 11% of control 
levels were found in liver tissue in a biopsy from her. When 
she was put on a galactose-free diet her jaundice abated, her 
liver function tests returned to normal and she thrived. When 
challenged with galactose her symptoms returned. The severity 
of her symptoms would suggest a different disorder from that 
described by Gitzelman, involving a more widespread 
deficiency.
Some galactose was included in her diet to allow the 
synthesis of galactosides but it has been difficult to find 
the correct level of supplementation (Henderson et al 1983). 
The ingestion of even small amounts of galactose result in a 
rapid rise in her red cell UDPgal but the concentration of 
gal-l-P was proportional to her galactose intake. The patient
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did not sit until 15 months old and had a development 
quotient of 70 at 19 months.
A second case of generalised epimerase deficiency was reported 
by Garibaldi et al (1983). They claimed that no epimerase 
activity could be detected in erythrocytes or fibroblasts, and 
that parental fibroblasts showed reduced epimerase activity. 
These findings suggested a similar defect to that described by 
Holton et al.
A third case has been reported (Sardharwalla 1988). this was 
a child whose aminoaciduria was detected by a newborn 
screening programme. She was unwell with poor feeding, 
vomiting, jaundice and hepatomegaly, and had to be treated for 
a staphylococcal septicaemia. She was given a 
galactose-restricted diet (not galactose-free) containing 30ml 
of cow's milk or lg of galactose per day. At 2 years and 9 
months she was severely mentally retarded with an IQ of 55 and 
had, importantly, profound sensori-neural deafness as did the 
index case reported by Holton. The amount of galactose 
required by children such as these is not known, and neither 
is the consequence of over or under supplementation. One of 
the purposes of the work described in this thesis is to enable 
reasoned choice* if any, required by such infants and to avoid 
the arbitary choice of dietary galactose content without 
knowledge of its requirement or consequence.
The only other report of an organism which had a consequential 
lack of epimerase was from Nikaido et al on mutants of 
salmonellae (Nikaido 1961, Fukasawa 1961). They found these 
cells to be deficient in epimerase and to accumulate 
intracellularly large amounts of UDPgal and gal-l-P when grown
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in medium containing galactose. Nikaido analysed the sugars 
in the cell walls of these mutants. Surprisingly the only 
sugar present was glucose, and they lacked any galactose, 
mannose, rhamnose or tyvelose which were present in the wild 
type cell wall.
1.2.8 Galactose toxicity
In transferase deficiency galactosaemia, exposure to galactose 
causes damage to brain, liver, kidney and the lens of the eye. 
Attempts to investigate galactose toxicity have been hampered 
by the lack of a suitable animal model. Diets high in 
galactose have been tried in chicks and young rats and can 
induce raised blood galactose, but since all enzymes are 
present the pattern of accumulation will not be the same as in 
the human galactosaemic. The toxic effects of galactosaemia 
vary from organ to organ, accordingly they will be considered 
individually.
The lens; this is damaged in transferase and kinase 
deficiency, indeed it is the only tissue known to be damaged 
in kinase deficiency. The formation of cataracts is 
undoubtedly associated in galactosaemics with the presence of 
galactitol. Aldose reductase is present in large quantities 
in the lens, and an inhibitor of that enzyme delayed cataract 
formation in galactose-fed rats (Peterson 1979). Galactitol 
is formed within the lens and diffuses out only with 
difficulty. The osmotic activity of galactitol in the lens is 
a likely cause of cataracts since in vitro incubation of lens 
in a medium whose osmolality is increased to balance the 
galactitol formed stops cataract formation.
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The liver: this is damaged in transferase deficiency but the 
pathogenesis is not well understood. There are however 
indications that a deficiency of nucleotides is a cause. 
Keppler et all have demonstrated increased catabolism of 
hepatic nucleotides in galactosaemics after a galactose load 
(Forster 1975). More recently they have shown that 
D-galactosone, a galactose analogue metabolised in the same 
wayas galactose causes a deficiency of UTP in hepatoma cells 
(Keppler 1982 ) .
The kidney: This is another tissue damaged in transferase 
deficieny. Gal-l-P and galactitol have both been found in the 
kidneys of transferase deficient subjects. However the 
aminoaciduria of transferase deficiency is not seen in kinase 
deficient subjects, who excrete large amounts of galactitol. 
Amnioaciduria has been induced in normal subjects to whom 
galactose was given intravenously (Fox 1964). Incubation of 
rat kidney cortex slices produces non-competitive inhibition 
of aminoacid accumulation by tubule cells. Thus it seems that 
gal-l-P rather than galactitol is the toxic agent and that it 
induces its effect by disturbing aminoacid transport.
The Brain: The manifestation of galactose toxicity which is 
argueably the least understood and most serious is mental 
retardation. Galactitol has been found in brains of subjects 
with transferase deficiency, and in rats fed galactose the 
level of accumulation in the brain is second only to that in 
the lens. However, the lack of any retardation associated 
with kinase deficiency makes a pathological role for 
galactitol unlikely. It has been hypothesised that a decrease 
in serotonin receptors is the cause, but no abnormality has
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been observed in the uptake of serotonin by the synaptosomes 
of galactose intoxicated rats (Yandrasitz 1979). However, 
interpretation of work on rats is difficult since they do not 
show acute brain toxicity on high galactose diets. The only 
fact that can be stated with certainty in this field is that 
the mechanism by which galactose causes toxicity in the brain 
remains to be found.
The immune system: Disruption of the immune system is not 
normally quoted as being on of the effects of galactosaemia 
but it is becoming apparent that it is a very significant and 
highly consequential effect of the disorder. Among 35 infants 
with classical galactosaemia discovered on newborn screening 
ten had systemic infection of which nine died despite therapy 
(Oski 1979). Escherichia coli was the causative organism in 
most cases. These observations prompted Kobayashi et al
(1983) to investigate in vitro neutrophil function using 
neutrophils from normal adults and neonates. They found that 
neutrophil function was depressed by galactose in adults and 
to an even greater extent in children. It is therefore clear 
that galactosaemia can compromise the immune system, and that 
this can have fatal consequences so rapidly that neonatal 
screening does not prevent death.
The ovary: There have been reports of a very high incidence of 
gonadal failure in female galactosaemics (eg Kaufman 1981, 
1988, 1989; Dessart 1982). Twelve out of 18 female 
galactosaemics had hypergonadotrophic hypogonadism and 11 had 
amenorrhoea. One suffered ovarian failure after an uneventful 
pregnancy and the birth of a normal child. Gonadal function 
in 8 male galactosaemics was normal. The mechanism by which
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this occurs is not known, but the possibility of toxic 
destruction of the ovaries during intrauterine life by a 
galactose metabolite has been suggested (Dessart 1982). 
Cellular toxicity: galactose toxicity is not limited to whole 
organs,toxic effects have been demonstrated against cells in 
culture. The growth of fibroblasts from transferase deficient 
subjects is inhibited by adding galactose to the medium. When 
these cells are incubated with galactose, electron microscopy 
shows dilation of the endoplasmic reticulum. Cytoplasmic 
degeneration and cell death occur within 3 days (Miller 1968). 
Galactosaemic fibroblasts also have impaired metabolism of 
sulphate when exposed to galactose (Tedesco 1979).
1.2.9 Toxicity in epimerase deficiency
The wide difference in clinical consequence between lesions of 
different enzymes in the same pathway is well illustrated by 
the contrast between kinase and transferase deficiency. 
However, it may be possible to hypothesise about some effects 
of epimerase deficiency in the light of our knowlege of the 
other defects of galactose metabolism. In epimerase 
deficiency gal-l-P is raised to a similar level to that found 
in transferase deficiency (Henderson et al 1983). Since 
gal-l-P has been implicated as causing the majority of the 
toxic effects of transferase deficiency then it is likely that 
these will be a feature of epimerase deficiency. Indeed 
abnormally high liver function tests, jaundice and 
aminoaciduria were observed in the reported case. This child 
also had markedly elevated UDPgal when not on a galactose-free 
diet. UDPgal is the substrate for galactosyl transferases
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which are responsible for galactosylating glycoproteins and 
glycolipids. It is possible that a galactose containing diet 
could induce greater degrees of galactosylation in such a 
subject by increasing the amount of substrate, and conversely 
a galactose-free diet could result in lower levels of 
galactosylation. The consequences of this are not known.
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Section Three: Cultured Cells and Inherited Disease
1.3.1 The history of cell culture
In 1907 Ross Harrison grew frog nervous tissue in clots of frog 
lymph, and it is generally accepted that this was the first 
true tissue culture. Techniques for culturing tumour cells 
developed slowly from that time. In 1914 Losee Ebelling was 
culturing human tumour cells and by 1936 Gey was able to do 
this on a considerable scale. He also showed that the culture 
of normal human cells was not as difficult as previously 
thought. However transformed lines like Hep 1 and HeLa which 
appeared to grow indefinitely were easier to use, and the 
degree to which these lines were abnormal was not fully 
realised at the time.
When the normal chromosome number was found to be 46 in 1956 
the use of primary cells received considerable stimulus, since 
these perpetual cell lines were found to be chromosomally 
abnormal.
Fortunately techniques soon developed for culturing normal 
fibroblasts. Puck (1958) showed that it is possible to grow 
cells from small skin biopsies by trypsinising the tissue and 
seeding out the cells. The plasma clot explant technique which 
was developed for growing fibroblasts from skin biopsies has 
also been used for many other tissues. At first human skin 
fibroblast cultures were used mainly for cytogenetic 
studies, then in 1960 Krooth and Weinberg found that 
fibroblasts from patients with galactosaemia failed to grow in 
a medium with galactose as the only energy source. Since then 
cultured cells have been used in many studies relating to 
inherited disease.
1.3.2 How cells are cultured
It is possible to grow cells from samples of almost any tissue. 
Some like liver are particularly difficult to grow, and from 
others a mixed population of epithelial cells and fibroblasts 
will grow, but fibroblasts always come to predominate. Almost 
pure epithelial cells can be obtained from tissues such as the 
kidney. However the vast majority of culture is carried out on 
samples that can be collected routinely from any subject 
without major risk, that is skin, blood and amniotic fluid.
A skin biopsy may be obtained easily and almost painlessly by 
picking a fold of skin with forceps and cutting of the top with 
a scalpel blade.
The biopsy is transported to a laboratory in culture medium. On 
arrival it is cut up into small pieces and these are anchored 
in culture vessels, for instance with clots of serum. Cells 
will grow out from the pieces of skin and after several days 
sufficient should be present for subculturing by removing them 
with a mixture of trypsin and EDTA.
Primary human cells cannot be cultured indefinitely but die 
out after about 50 - 60 doublings for embryonic fibroblasts and 
30 - 40 for those of adults (Hayflick 1965). Cells with 
metabolic abnormalities may not even grow for this period. 
Amnotic fluid cells
Cells from amniotic fluid are harder to grow than those from 
skin biopsies. Normally a few mis of amniotic fluid are mixed 
with cell culture medium and incubated in a culture vessel.




This may be either long or short term. For short term culture 
whole blood or purified lymphocytes is mixed with culture 
medium containing phytohaemagluttinin (PHA) or another similar 
mitogen. After 48-72 h large numbers of cells are in mitosis. 
However the cells will only continue to divide for two or three 
cycles which limits the usefulness of this method. Long-term 
culture of lymphoid cell lines may be established by exposing 
the cultures to high concentrations of Ebstein-Barr virus 
(EBV). Virus transformed B lymphocytes will then grow out. If 
such cells are used for the study of inherited disease then it 
should be remembered that the EBV genome is expressed in these 
cells. One advantage with B lymphocytes is that since the 
cells grow in suspension it is possible to grow very large 
numbers quite easily.
1.3.3 Cryopreservation
Cultured cells may be stored for long periods in liquid 
nitrogen and yet remain viable, ie capable of growth and 
division on thawing.
Cells must be frozen in the presence of a cryoprotective agent 
such as DMSO. The rate of cooling is important, normally cells 
are cooled slowly (about 1°C per minute) to -30°, then quickly 
(10° per minute) to -196°. Cells may be stored for many years 
in this state.
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1.3.4 Cultured cells and the diagnosis of inherited disease
Many inherited diseaes may be diagnosed by establishing the 
existence of an enzyme deficiency in cultured cells, indeed 
I-cell disease takes its name from inclusions found in cultured 
cells. This is a relatively recent advance which has become 
possible as the exact nature of the lesion in many inherited 
diseases has been found.
Substrate accumulation in vivo is often a useful indicator of 
the cause of a disorder, but when a diagnosis remains with an 
affected case for life then the exact nature of the enzyme 
defect should be established if possible. Erythrocytes are the 
most easily obtained cell but they contain only cytoplasmic 
enzymes, and lacking nuclei they cannot be cultured. They can 
however be used for the study of cytoplasmic enzyme 
abnormalities such as hypoxanthine guanine phosphoribosyl 
transferase deficiency in Lesch-Nyhan syndrome (Dancis 1973). 
Leucocytes and fibroblasts may be used as relatively 
undifferentiated cells, ie ones in which a large number of 
enzymes are expressed which are not relevant to the particular 
function of that cell. For most diseases both 
polymorphonuclear leucocytes and cultured skin fibroblasts may 
be used for diagnosis (Milunsky 1972). However if cells have 
to be stored before or after enzyme assay then fibroblasts 
are normally used since transformation is not necessary.
1.3.5 Cultured cells as models for inherited diseases 
Cultured cells from a subject with an inherited disease may be 
used as a model for that disease in preference to carrying out 
experiments on that subject. Indeed the first use of cultured
31
cells in the study of inborn errors was as a model rather than 
for diagnosis when Krooth and Weinberg showed that fibrolasts 
from a patient with galactosaemia failed to grow in a medium 
with galactose as its main energy source (1960).
Since then many inherited diseases have been investigated in 
culture ranging from sulphatase deficiency (Roy 1977) to 
gangliosidoses (Galjaard 1977) and familial 
hypercholesterolaemia (Robertson 1977).
Fibroblasts are normally preferred since cells are usually 
cultured for a longer time than for diagnosis. Transformation 
would therefore be required for lymphocytes, but for 
fibroblasts no viral or mitogenic stimulation is needed, adding 
to their validity as a model.
If it is merely the intracellular biochemistry that is under 
examination the fibroblasts provide an excellent model since 
very large number of enzymes are expressed in them. The 
external biochemical environment can also be controlled for 
cultured cells in a manner not possible in vivo, and 
radiolabelled compounds can be fed to cells and their 
catabolism followed, which also may not be possible with living 
subjects.
There are however limitations to the use of cultured cells as a 
model for inherited disease. Some enzymes are simply not 
expressed in fibroblasts, often those which are found 
exclusively in liver such as phenylalanine hydroxylase, whose 
deficiency causes phenylketonuria.
Even if the enzyme under consideration is expressed then there 
is a possibility that other relevant enzymes may not be 
present, such as those synthesising toxic by-products from
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metabolites accumulating behind an enzyme block, thus giving a 
misleading picture. Lastly such a model cannot give 
information about a damage to a particular tissue, for instance 
the lens of the eye or ovary in galactosaemia.
1.3.6 Problems with cell culture
There are several other problems that arise in the practice of 
tissue culture. One is that the metabolism of cells in culture 
may not be the same as that in vivo. Rapidly proliferating 
cells are often said to de-differentiate (Hardnen 1977). They 
acquire high levels of glycolysis and there is evidence for 
switches in enzyme function.
For instance Owens and Nebert (1975) showed that in a wide 
range of cultured tissues the cytochrome P450 oxidase is hard 
to activate, whereas the P448 which is characteristic of more 
rapidly dividing cells seems to take over its function. Drugs 
which induce P450 in vivo induce P448 in culture.
A second problem is contamination of the culture. Bacterial 
contamination could conceivably lead to erroneous results but 
is usually obvious. Infection with mycoplasma is usually more 
occult and is known to cause alterations in metabolism and 
chromosomal abnormalities. It has also been shown that 
mycoplasma infection can produce apparently normal enzyme 
activities in cells deficient in hypoxanthine guanine 
phosphoribosyl transferase (HGPRT) (Stanbridge 1975) and induce 
a 10-fold increase in pyruvate dehydrogenase activity 
in deficient cells. Mycoplasma may be detected in cultured 
cells by staining with a fluorescent dye and examination under 
a UV microscope.
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Continuous vigilance of cultures is obviously important. 
Contamination with virus is easily detected since it usually 
destroys the culture, however it is a rare occurence. The last 
source of contamination is other cells. It has been shown that 
a large proportion of established cell lines are in fact HeLa 
cells (Gartler 1968). Fortunately cells from patients with 
inborn errors have built-in markers.
One final problem is the artifical correction of a defect by 
absorptive pinocytosis of the missing enzyme from the cell 
culture medium by deficient cells. This has been documented in 
mucopolysaccharidoses (Neufeld 1973). Media conditioned by 
normal cells have enough enzyme activity to normalise 
mucopolysaccharide storage in mutant cells. It has since been 
shown that normal cells can transfer to mutant cells N-acetyl 
(3-D-hexosaminidase, but not a glucosidase or (3-galactosidase.
It has been recognised that human serum should not be used for 
culture in this field because of the possible presence 
of corrective factors.
1.3.7 Culture medium and fibroblast metabolism 
The environment of cultured cells consists of the culture 
medium, a solid support on which cells grow and a neighbouring 
gas phase.
The principal influence on the metabolism of cultured cells is 
the composition of the medium. Initially media were derived 
from body fluids, now synthetic media are used to which serum 
is added as a supplement. The basic components of a synthetic 
medium are a salt mixture, an energy source and some vitamins. 
In addition a buffer is needed to maintain the pH and a serum
34
content of between 2 and 20% is necessary for diploid cell 
growth and division. All these components may influence the 
metabolism of cells.
Salt mixture
Medium must be of an appropriate osmotic tension, about 300 
mosmol/kg, the bulk of which is contributed by sodium chloride, 
but fibroblasts can tolerate quite large changes (about 10%) in 
osmotic pressure without apparent effects on metabolism (Paul 
1975). Other ions are essential components of cell metabolism. 
Magnesium and calcium are required to anchor cells to surfaces 
and are important in many stages of intermediary metabolism. 
Magnesium for instance is necessary in all transphosphorylation 
reactions. Zinc and iron are required for cell growth but the 
need for other trace elements is unclear. The only recorded 
effect of salt composition on cells with inborn errors of 
metabolism is the ability of magnesium concentration to affect 
HGPRT (Benke 1973), however other enzymes may show dependance 
on divalent cation concentration.
Energy source
The most widely used energy source is glucose though other 
saccharides may replace it. The metabolism of glucose is 
mainly glycolytic, resulting in the accumulation of lactate in 
the medium. However, cells do not possess all the enzymes 
necessary for respiration and the pentose phosphate shunt, and 
the balance between glycolysis and respiration can be varied 
according to cultural conditions.
Inhibition of respiration by anaerobic conditions causes 
increased glycolysis (the Pasteur effect) while increased
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concentrations of glucose may inhibit respiration (Crabtree 
effect). Increased glucose concentration may also promote 
glycolysis.
The first metabolic deficiency detected in fibroblasts was 
galactosaemia, shown by the inability of the fibroblasts to use 
galactose instead of glucose as an energy source. It has also 
been shown (Zacchello 1972) that galactose in the medium will 
induce galactokinase activity in normal subjects and 
heterozygotes for kinase deficiency.
Amino acids: No cultured cells have been shown not to grow in
the absence of eight essential amino acids required by man. In 
addition five other amino acids are required in vitro: 
glutamine, arginine, tyrosine and histidine which are 
synthesised in the liver of intact organisms, and cystine. 
Non-essential amino acids are often added to stimulate growth. 
No studies have shown any consequences of amino acid 
composition on metabolic processes relevant to inherited 
diseases.
Vitamins: Eight vitamins are required by cultured cells, six
of which function as co-enzymes. There are specific inherited 
diseases involving vitamins, but they can also affect cells 
with other abnormalities. Vitamin C causes a marked rise in 
intracellular mucopolysaccharides in cells from patients with 
Hurler's syndrome (Schafer 1966) and a less marked change in 
normal cells. The B vitamin responsive errors of metabolism 
are well known and this response can be shown in tissue 
culture. For instance the addition of 5'deoxyadenosyl- 
cobalamin corrected the metabolic abnormality in cells from a 
patient affected with methylmalonic acidaemia (Kaye 1974).
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pH and carbon dioxide: Cells in culture must be maintained 
within narrow pH limits in order to grow properly. Until 
recently the usual buffering system was bicarbonate / carbon 
dioxide which gave an appropriate pH when in equilibrium with 
5% CO2 in the gas phase. However this requires an artificial 
gas phase and is not a very strong buffer since the required 
pH is some way from the pKa of bicarbonate at 6.1. Organic 
buffers such as Hepes are now often used since they are more 
effective buffers and do not significantly change pH with 
temperature. However it does seem that bicarbonate is 
essential for normal cell growth, possibly because the absence 
of CO2 causes decarboxylation of oxaloacetate with consequent 
cessation of cell respiration and there is also a CO2 fixing 
step in de novo ATP biosynthesis. Oxaloacetate restores 
growth in CO2 deprived cultures. Changes of pH have many 
effects on metabolism including on morphology, glycolysis, 
growth, membrane transport, mucopolysaccharide production and 
collagen production (Lie 1977).
Serum: Completely synthetic media can be used for some
heteroploid cell lines but human diploid fibroblasts require 
serum for growth. Serum has many effects on metabolism, 
increasing transport of various nutrients and stimulating 
protein and DNA synthesis. The main effect detected which 
concerns inherited diseases is the alteration in lysosomal 
enzymes with changes in serum concentration, for instance 
B-galactosidase tends to be lower at higher serum 
concentrations (Lie 1977).
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1.3.8 Galactosaemia and cultured cells
As already mentioned, the paper by Krooth and Weinberg was the
first on inherited disease cells in culture. In it they
showed that while normal fibroblasts grew equally well with
100mg% galactose or glucose as their energy source,
transferase deficient cells grew normally with glucose but
equally slowly in a galactose or a hexose-free medium.
Heterozygotes gave variable results but were predominantly
equal in galactose or glucose. They also compared growth in
media containing 95mg% galactose and 5mg% glucose with that
containing just 5 mg% glucose. Normal and heterozygote cells
grew equally well in the two media but transferase deficient
cells grew better in just 5mg% glucose, and growth was slowed
for the first 72 hours by adding galactose. Deficient cells
14were not able to produce CC>2 from radiolabelled galactose, 
unlike normal controls.
Miller and coworkers examined the cytologic effect of media 
containing galactose on galactosaemic fibroblasts in culture. 
They observed changes they describe as remarkable using 100 mg 
of galactose per 100 ml of media (Miller 1968). Loss of 
electron dense material in the lumen of the rough endoplasmic 
reticulum was followed by massive dilatation of the reticulum 
tubules. Degeneration and cell death were evident after 72 
hours. The galactose containing medium was selectively toxic 
for the galactosaemic line.
Work done on a cultured cell model for familial 
hypercholesterolaemia has recently been found to have a 
fascinating relevance to galactosaemia. Krieger et al (1983) 
produced a CHO mutant cell line defective in low-density
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lipoprotein (LDL) receptors by growing cells in a high 
concentration of amphotericin B. These cells have subsequently 
been found to have no measurable epimerase activity and it has 
been proposed that their inability to synthesis galactose 
prevents the formation of LDL receptors, of which galactose is 
an essential component. They therefore would seem to be a 
cellular model for complete epimerase deficiency.
Other relevant work has been carried out in cell lines which 
do not have disorders of galactose metabolism. King and Pope
(1984) showed that all-trans retinoic acid increased the rate 
of incorporation of galactose into glycoproteins in cultured 
pig skin slices. The incorporation of glucosamine and leucine 
were not affected, and there was no evidence for the synthesis 
of new types of glycoprotein. Schwarz and coworkers examined 
the ability of brain cells from neonatal mice to metabolise 
galactose (1985). They found that galactose was much less 
readily consumed than glucose and that even low levels of 
glucose could reduce the uptake of galactose, whereas 
galactose at concentrations of up to 11.6 mmol/1 did not 
inhibit glucose uptake.
Lactate was consumed from the medium at all galactose 
concentrations whereas glucose caused the release of lactate 
by cells. They concluded that galactose is poorly metabolised 
by brain cells but does not exhibit toxic effects.
The addition of galactose to culture medium has been shown to 
protect CHO cells from a thermal shock to 45°C to a greater 
extent than either glucose or mannose (Henle 1984). Neutra and 
Leblond (1966) showed that when labelled galactose was taken 
up by cells it was located first in the Golgi region then in
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secretory products such as mucins. They concluded that the 
synthesis of complex carbohydrates takes place in the Golgi 
region of many secretory cells. The other area of study 
combining galactose and tissue culture relates to malignancy. 
Klohs et al (1984) found that UDPgal inhibited the growth of 
mouse leukaemic L1210 cells by up to 92%. Other nucleotide 
sugars as well as galactose, glucose and gal-l-P had no 
effect. This inhibition was not observed with lines such as 
3T12, which did not secrete galactosyl transferase activity 
into the medium. Normal growth was resumed when UDPgal was 
removed from the medium. They suggest that UDPgal inhibition 
of cell growth requires galactosyl transferase activity, and 
that the effect is mediated via the cell membrane. They 
hypothesise that either the addition of galactose to a cell 
surface glycoconjugate signals the cell to stop dividing, or 
that it prevents hormones or growth factors from binding to 
the membrane. The implication for these findings on disorders 
of galactose metabolism have not been considered. Other work 
has investigated the production of abberant cell surface 
carbohydrates by malignant cells, for example 56% of labelled 
galactose incorproated into F9 embryonal carcinoma cells was 
found on the plasma membrane (Kawamoto 1983).
Section 4; Lectins
1.4.1 Introduction
A lectin is a carbohydrate binding protein of non-immune 
origin which agglutinates cells and/or precipitates 
glycoconjugates (Goldstein 1986). Most lectins come from 
plants; however they have also been found in a range of 
organisms including bacteria, sponges, fish, molluscs and 
mammals. No purified lectin has been shown to exhibit enzyme 
activity. Lectins were discovered during work to isolate the 
highly toxic principle of various seeds, including castor 
beans and jequirity and croton seeds. Extracts of the cells 
were found to agglutinate red blood cells, and research was 
stimulated by the realisation that certain lectins could be 
used as blood typing reagents. Since then, they have found 
many other uses as experimental tools. As mitogenic stimulants 
they have wide application in immunology and cytogenetics. As 
structural probes lectins have revealed much about the 
organisation of the cell surface, and its changes during the 
cell cycle and malignant transformation. Lastly, the 
saccharide binding properties of lectins have been used in a 
number of analytical and preparative procedures for 
characterising, sequencing and purifying carbohydrates, 
glycoproteins and glycopeptides. All of these effects of 
lectins are inhibited or abolished by the carbohydrate for 
which the lectin is specific.
1.4.2 Specificity
In order to interpretate the results of experiments with 
lectins their carbohydrate binding specificity must be known.
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Sugar - lectin complementarity is usually determined by 
the Landsteiner hapten inhibition technique (Landsteiner 
1962). This is done by comparing sugars on the basis of the 
minimum concentration required to inhibit the precipitation 
reaction between a lectin and a reactive macromolecule, or the 
haemagglutination reaction. A number of other procedures have 
given information on carbohydrate binding specificity, 
including elution from solid phase adsorbents, precipitation 
studies with synthetic carbohydrates (eg Lonngren 1976); 
ultraviolet spectroscopy, fluorescence spectroscopy and 
equilibrium dialysis.
The C-4 hydoxyl group of carbohydrates is critically involved 
in lectin binding. Galactose binding lectins do not interact 
with glucose or mannose (Hayes 1974, Nicholson 1974). This 
makes them particularly useful for detecting galactose in the 
presence of other carbohydrates.
Some lectins have been shown to contain sites which bind non­
carbohydrate compounds. Concanavalin A and a number of 
leguminous lectins bind fluorescent hydrophobic molecules such 
as 1,8-anilino naphthalenesulphonic acid. Lima bean lectin 
has a single high affinity site for adenine, as do lectins 
from Dolichos biflorus, Phaesolus vulgaris and Glycine max 
(Roberts 1983 ) .
1.4.3 Ricin Lectin
Lectins from the castor bean, Ricinus communis has been used 
in several of the experiments described in this thesis.
Aqueous extracts of the castor bean contain two distinct but 
structurally related lectins: a very cytotoxic weak
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haemagglutinin and a strong erythroagglutinin that is only a 
weak inhibitor of protein synthesis (Olsnes 1978). These two 
components are termed ricinus communis toxin (ricin or RCA II) 
and ricinus communis agglutinin (RCA I). They can be 
separated by a number of affinity chromatography methods, for 
example sequential elution from Sepharose 4B of the toxin with 
N-acetyl hexosamine and the agglutinin with galactose.
RCA I is a tetramer of molecular weight 120000 Daltons. It 
has a large number of interchain disulphide bonds, and perhaps 
because of this it is a robust molecule, resistant to repeated 
freezing and thawing, pH changes and proteolysis (Olsnes 1976, 
Ishigino 1964, Olsnes 1975).
RCA I binds galactose and galactosides, with the specificity:
beta-galactose > alpha-galactose > N-acetylgalactose
(Goldstein 1986). It binds two molecules of the saccharide
3 4with Ka - 1.24 x 10 and 3.8 x 10 per mole for galactose and 
lactose respectively, at 4°C (Goldstein 1986). The relative 
inhibitory potencies of a number of sugars are shown in table
I from Goldstein 1986. From this table it can be seen that 
lactose is 7-8 times more potent an inhibitor of agglutination 
than galactose. This, combined with the other results in the 
table suggest that the binding site of the agglutinin is an 
extended one, capable of binding to the glucose unit of 
lactose and probably interacting with the C-4 and C-6 hydroxyl 
groups of the beta galactosyl unit. Extensive studies of the 
interaction of glycopeptides with RCA I and RCA
II are in general agreement with the results found for simple
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saccharides (Debray 1981). A recent comprehensive review of 
the properties of lectins does not record any observations of 
binding of non-carbohydrates by RCA I (Goldstein 1986).



















Neu5Ac 2,3Gal l,4Glc 4.0
Neu5Ac 2,6Gal l,4Glc 16
From Goldstein 1986
Table 1. Binding of carbohydrates by RCAl
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1.4.4 Lectins in the study of cells
Sugars constitute 2-10% of the mass of cell membranes, and the 
glycoproteins which they make up provide the cell with 
recognition patterns and give cells their individuality. 
Lectins are excellent probes for these cell surface components 
because they are specific, attach tightly and reversibly, and 
do not normally enter the cell. The simplest reaction of a 
lectin with cells is agglutination. However lectins can bind 
to cells without causing agglutination, and may cause other 
dramatic events in the life of a cell, for instance the 
stimulation of lymphocytes to undergo cell growth and 
division. This is known as mitogenis or lymphocyte 
transformation.
These actions of lectins may be inhibited by saccharides for 
which the lectin is specific. This may be taken as evidence 
that the receptor for the lectin contains a structure which is 
at least similar though not necessarily identical to that 
sugar. These saccharide receptors are components of membrane 
glycoproteins and glycolipids. Carbohydrate structures which 
strongly inhibit lectins appear to be a common occurence in a 
variety of glycoproteins. Such inhibitors of lectins are 
normally termed lectin receptors (Sharon 1975) although 
they do not necessarily communicate any signal to the inside 
of the cell.
It has been shown (eg Hammarstrom 1973) that association 
constants for the binding of lectins to cells are several 
orders of magnitude higher than those for binding the specific 
oligo- or monosaccharide for that lectin. This may be because 
the lectin receptors are more complex than the simple
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oligosaccharides used in binding studies and lectins have a 
greater affinity for these extended sites, or lectins, being 
multivalent, may bind at more than one site. A third 
possible explanation is that non-specific interactions such as 
hydrophobic bonding may add to the strength of binding. It is 
well established that certain lectins do not compete for 
binding sites, indicating that their receptors are not only 
chemically different but also sufficiently far apart to 
prevent steric hinderance.
The presence of lectin receptors is easily demonstrated on 
cells by use of lectin derivatives, usually fluorescent or 
radiolabelled lectins. The methods used are generally similar 
to those developed by immunologists for the study of cell 
surface antigens. It is of course essential to ascertain that 
the binding is specific, eg it is inhibited or reversed by the 
appropriate saccharides. Fluorescent lectins may be 
visualised on intact cells in the light microscope under 
ultraviolet light. The amount of bound lectin may be 
determined by fluorimetry, or by measurement of radioactivity 
if radiolabelled lectins are used, and the data may be 
analysed by modifications of the Scatchard equation (Sharon 
1975). A linear plot suggests a bimolecular reaction with a 
single equilibrium constant for all cell receptor 
interactions. A curvilinear plot of upward concavity suggests 
either a heterogenous receptor population or the existence of 
site - site interactions.
Lectins bind to the carbohydrate portions of glycoproteins and 
glycolipids that protude from cells. This conclusion is based 
on the observation that lectin binding is affected by
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modification of cell surface sugars by glycosidases, 
glycosyltransferases, galactose oxidase and periodate. 
Similarly, treatment of cells with trypsin can cause a 
decrease of 35 - 50% in the number of lectin receptors 
(Kornfield 1969) presumably by removing the proteins to which 
they are attached. Unmasking of subterminal galactose 
residues of human lymphocytes or erythrocytes by enzymatic 
removal of sialic acid increases the amount of peanut agglutin 
bound by 20 to 40-fold (Carter 1977). Treatment of cells with 
neuraminidase increases binding of the galactose specific 
lectins RCA I and soya bean agglutin (Nicholson 1973) probably 
by revealing sites masked by neuraminic acid. Oxidation of 
galactose residues on the surface of human erythrocytes by 
galactose oxidase reduces the amount of soya bean agglutin 
bound by up to 90% (Lis 1982). In this case the receptors 
appear to be glycolipids. There is thus very good evidence 
for the specificity of lectins in binding to the carbohydrate 
portion of cell surface glycoproteins and glycolipids.
On both intact cells and isolated membranes lectin receptors 
are found on the outer and not the inner surface of the 
membrane (Nicholson 1978). This is consistent with findings 
obtained by other methods such as surface labelling with 
galactose oxidase and tritiated sodium borohydride, and 
provides strong evidence for the asymmetry of surface 
membranes. Asymmetric distribution of lectin receptors has 
also been found on intracellular membranes. There is 
increasing evidence that the binding sites are located on the 
cisternal (noncytoplasmic) side of many membranes, including
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the nuclear envelope, the mitochondrial outer membane, 
chromaffin granules and the Golgi apparatus.
1.4.5 Lectin resistance
The cytotoxic properties and sugar specificities of lectins 
make them ideal for the study of cell variants with altered 
cell surface carbohydrates. Toxic lectins may be used to 
select cells with non-lethal defects of glycosylation. Cells 
are grown in the presence of concentrations of cytotoxic 
lectin that will kill most cells in the normal cell line but 
will permit resistant mutants to survive. Colonies of 
surviving cells may be cloned and in some of those clones 
acquisition of resistance may be accompanied by changes in the 
glycosylation of the cell surface. Such cells retain 
resistance to lectin even when cultured for several months in 
their absence and are therefore apparently stable mutants with 
low reversion rates. In many cases the biochemical basis for 
resistance has been found, for instance Hela cells resistant 
to ricin have an altered sialyltransferase, and mouse lymphoma 
and CHO cells resistant to PHA have an abberant GlcNAc 
transferase. Generally resistance correlates with decreased 
lectin binding capacity, although some mutants have unaltered 
binding. There are two ways in which cells may reduce their 
capacity to bind lectins: the sugar residues may be masked or 
sterically hindered, possibly by additional sugars, or they 
may be deleted from the oligosaccharide.
Both types of structural change have been found in resistant 
cells. Emergence of resistance may be the result of deletion 
of a single enzyme, but often seems to be the result of
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changes in the activity of several glycosyltransferases. 
Masking of ricin receptors has been shown in baby hamster 
kidney and mouse L cells (Briles 1982 Stanley 1980). These 
variants contain much higher levels of sialyltransferase 
activity than wild type cells. The extra sialic acid residues 
are linked to and mask galactose residues that normally serve 
as ricin binding sites.
Oligosaccharide deletions have been found for a number of 
sugars and affecting cells to varying degrees. In a wheat germ 
agglutin (WGA) resistant CHO line the cells have a sialic acid 
deficiency in their oligosaccharides (Briles 1981). Such 
deletions may range from almost complete absence of sialic 
acid to a deficiency only of sialic acid residues with 
specific linkages, for instance 2 - 6 to galactose.
These variants have a decreased ability to bind wheat germ 
agglutin but an increased number of terminal galactose 
residues to which ricin may bind, which explains the 
hypersensitivity of these variants to ricin. Interestingly 
these cells appear to possess all the elements necessary for 
sialylation, namely the sugar nucleotide donor, acceptor and 
transferases (both 2 - 3  and 2 - 6 )  since extracts of these 
cells are capable of carrying out sialylation to the same 
extent as wild type cells. This suggests that the defect is 
somewhere in the intracellular organisation of protein 
biosynthesis (Briles 1982).
Variants of mouse lymphoma cells have an almost complete 
absence of fucose (Briles 1982 Reitman 1980). These variants 
are specifically deficient in GDP mannose - 4,6 -dehydratase, 
an enzyme that participates in the conversion of GDP mannose
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to GDP - L - fucose. Fucose is required for pea lectin to 
bind, hence the resistance of these cells to pea lectin.
A number of interesting variants have been found which are 
deficient in both sialic acid and galactose. The sialic acid 
deficiency is presumably secondary to the galactose 
deficiency, since sialic acid normally follows galactose in 
oligosaccharide chains. In these cells glycolipids appear to 
be affected as well as glycoproteins. One of the best 
researched of these is a CHO variant called clone 13 which 
contains only 12-15% of wild type levels of galactose and 
sialic acid in its membranes and shows much reduced binding of 
WGA and ricin compared to wild type cells (Briles 1981). Clone 
13 contains normal levels of UDPgalactose, suggesting that 
impaired galactose synthesis cannot account for the defect. 
Three other galactosylation defective variants have been 
selected from mouse lymphoma cells, Swiss mouse 3T3 cells and 
CHO cells. In these experiments PHA, GS I and abrin 
respectively were used as the cytotoxic agents (Briles 1982). 
The mouse lymphoma variant fails to add galactose to its 
Asn-linked complex oligosaccharides as shown by labelling 
studies and glycopeptide analysis, even though in vitro its 
galactosyl transferase and epimerase appear to be normal 
(Trowbridge 1978). In the GS I resistant variant, a similar 
failure to galactosylate has not been shown directly, but may 
be inferred from cytotoxicity and lectin binding studies which 
show a greatly reduced binding of both ricin and GS I, 
but increased binding and sensitivity to GS II, a lectin which 
is specific for terminal non-reducing N-acetyl D-glucosamine 
groups (Stanley 1979). A similar lectin binding pattern is
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observed with the abrin resistant CHO line described by Li et 
al (1980). As with clone 13 no galactosyl transferase 
deficiencies were found in these variants. Since these lines 
contain the elements necessary for galactoside biosynthesis it 
is likely that the defect involves intracellular organisation, 
as with the sialylation defect described above.
More extensive deletions have been found in resistant cells 
that lack the entire outer branch of complex or 
N-acetyllactosamine type glycosidic units, consisting of 
sialic acid, galactose and N-acetylglucosamine (Briles 1982 
Stanley 1980). These variants show decreased binding of 
lectins binding to outer branches, eg WGA, ricin, PHA and 
lentil lectin. They have an increased mannose content and are 
therefore more sensitve to conA cytotoxicity than wild type 
cells.
A ricin resistant mutant of baby hamster kidney cells had an 
accumulation of oligomannose glycans (Hughes 1983). Sialylated 
N-acetyl lactosamine type glycans were either absent or 
greatly reduced. Interestingly, these alterations were 
expressed in fibronectin, a secreted glycoprotein, as well as 
cell surface glycoproteins.
In all the variants discussed above the structural alterations 
are in the N-acetyllactosamine chains of glycoproteins.
Another class of variants have been produced by selection for 
resistance to conA in which deletions occur in the 
oligomannose units (Briles 1982).
As well as helping investigation into the biosynthesis of 
carbohydrate chains lectin resistant mutants provide insight 
into the biologocal role of cell surface sugars. A ricin
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resistant mutant derived from canine kidney cells is unable to 
incorporate galactose or sialic acid. However it retains the 
structural polarity characteristic of epithelial cells and the 
ability to develope tight junctions (Meiss 1982). In contrast 
to this lack of consequence of an oligosaccharide deletion, a 
rat L6 myoblast cell line resistant to conA was unable to 
undergo normal cellular differentiation to form myotubes. A 
high correlation was found between lectin resistance and loss 
of fusion potential, indicating that the two properties were 
probably related (Parfett 1981). No variant has been reported 
that is more than three times more resisitant than wild type 
cells to conA: more drastic alterations decreasing conA 
binding further appear to be lethal to cells.
It is however clear that a number of variants with severly 
truncated glycoprotein chains can be isolated. This is 
compelling evidence that all complex chains are not essential 
for cell viability.
1.5. Aim of this work.
Techniques of tissue culture have not been very extensively 
applied to inherited diseases of galactose metabolism and the 
effect of epimerase deficiency on cells is not known. Cell 
culture media can affect the metabolism of cells with enzyme 
disorders in many ways but this has not been considered with 
respect to disorders of galactose metabolism. The toxicity of 
galactose on cells lacking epimerase is not known. Whilst 
lectins have been used to produce mutant cells lacking certain 
enzymes and to study the effect of that lack on glycoproteins, 
they have not been used to investigate the effects of
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inherited diseases of galactose metabolism on glycoproteins. 
The aims of this project are therefore:
1. To examine the galactose content of tissue culture media 
with a view to producing an environment with a known galactose 
content for growing cells.
2. To examine the ability of epimerase deficient cells to grow 
without galactose and to establish the existence and extent of 
any requirement for galactose supplementation that they may 
have.
3. To investigate the applications of lectins to the 
investigation of inherited diseases of galactose metabolism.
4. To establish whether galactose is toxic to epimerase 
deficient cells.
5. To determine whether epimerase and transferase deficient 





All cell culture materials including tissue culture vessels, 
culture media and foetal calf serum were obtained from Gibco 
Ltd., Trident House, Renfrew Road, Paisley, Scotland. All cell 
lines were from the stocks held at the South West Regional 
Cytogenetics Laboratory, Southmead Hospital, Bristol except 
both Chinese Hamster Ovary cell lines which were a gift of 
Professor Monty Krieger, Department of Biology, Massachusetts 
Institute of Technology, Cambridge, Massachusetts, USA, and 
human fibroblasts line ED2, given by Professor Luigi Garibaldi, 
Department of Pediatrics, Institutio G. Gaslini, Genoa, Italy.
Bulk liquids including all solvents, aqueous acids and Cocktail 
T scintillant were 'AnalaR' grade and came for BDH Chemicals, 
Ferris and Company Ltd., Kenn Road, Bristol.
Isotopically labelled compounds were produced by New England 
Nuclear and supplied by Du Pont (UK) Ltd. of Southampton. The 
carbon-14 galactose used had the isotopic labelling distributed 
throughout the carbon skeleton. All other chemicals, reagents, 
enzymes, lectins and smaller items of equipment including 
dialysis tubing and filters were purchased from Sigma chemical 
Co. Ltd., Fancy Road, Poole, Dorset.
The following pieces of equipment were used:
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A laminar downflow recirculating sterile work station from MDH 
Ltd.
A Kl thermostatic compact incubation (LEEC Ltd.).
A 35 HL Liquid Nitrogen refrigerator (Union Carbide Ltd.).
A Zeiss standard 3 objective microscope and a Prior monocular 
inverted microscope.
A Shimadzu fluorimeter.
An LKB 1210 Ultrabeta Liquid Scintillation Counter 




Section 3.1 Cell Culture
3.1.1 Sterility
Cell culture was carried out by conventional techniques for 
the growth of human fibroblasts and Chinese Hamster Ovary 
Cells (CHO cells). Normal precautions were taken to ensure 
that solutions and equipment did not become contaminated with 
micro-organisms. In particular, all work with open solutions 
or culture vessels was carried out in a laminar downflow work 
station. Solutions which required sterilisation were either 
autoclaved at 121°C for 15 minutes or were filter sterilised. 
Small volumes (less than 50ml) were filtered through Millex GV 
filters, larger volumes (up to about 200 mis) through 
Sterivex-GS filters and volumes greater than this through 
Falcon 7103 filtration units.
3.1.2 Establishing Cultures
Skin biopsies were taken by clinicians from children who were
known to be affected with relevant inherited diseases.
Biopsies were taken according to the method of Edwards.
The forearm or iliac crest was used. The surface of the skin
was cleaned with ether and allowed to dry. A piece of skin
was pinched between forceps and the top sliced off with a
scalpel to a sufficient depth to include the whole thickness
of the epidermis. The biopsies were transported to the
laboratory in normal growth medium in a sterile container.
The biopsy was then dissected with forceps into pieces
approximately 1 mm cubed. The pieces were divided between
two tissue culture flasks and anchored in place by plasma
do g/L)
clots. For this 0.1 ml CaCl0 solution was added to 0.5 ml of
* /v
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human plasma. A few drops of this recalcified plasma was 
placed on each explant and left to clot. Five mis of warmed 
growth medium was then added to each flask. The growth 
medium was changed every 2 days until sufficient fibroblasts 
had grown from the explant to allow subculture.
3.1.3 Subculture
Cells were removed from flasks containing explants or cell 
monolayers with versene/trypsin solution (VT). The medium 
was discarded and the flask washed with warmed PBS. This was 
discarded and replaced with VT, 5 mis for small flasks and 12 
mis for large flasks. The flask was then incubated until 
cells were rounded and free from the flask surface. The cell 
suspension was then centrifuged in a bench top centrifuge at 
1000 rpm for 5 minutes. The supernatant was then discarded 
and the cells resuspended in growth medium. This was divided 
between culture vessels as required with a split ratio of 1:2 
or 1:3. Growth medium was then added to a level of 
approximately 0.2 mls/square cm of culture area.
Subculture number was recorded each time and cells were not 
used past subculture number 15.
3.1.4 Freezing
Cells were frozen using dimethyl sulphoxide (DMSO) as a
cryoprotectant. Three ampoules could be produced from every 
2
75 cm flask. Cells were trypsinised as for sub-culturing 
but the cells were resuspended in medium containing 5% DMSO in 
the amount of 3 mis of medium for every 75 cm flask, and if 
more was used then all cells of each line were pooled. The
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cell count was determined and 1 ml of suspension dispensed 
into each ampoule. Ampoules were then labelled and a record 
card written recording the name, disorder, subculture number 
and cell count. The cells were frozen in a plasma cell 
freezer at a rate of -1°C per minute to -30°C then -10°C per 
minute to -190°C. The frozen cells were then transfered to 
the liquid nitrogen storage bank for long term storage.
3.1.5 Counting cells.
Cells were counted in an Improved Neubauer counting chamber.
A drop of cell suspension was put into the counting chamber 
which was then examined under a microscope. The cells in 
four large (1 mm x 1 mm) squares were counted with the aid of 
a tally counter and the average number per square found.
This was multiplied by 10000 to give the number of cells per 
m l .
3.1.6 Recovering cells from liquid nitrogen.
Ampoules were removed from liquid nitrogen and quickly placed
in a 37°C water bath. When thawed, the contents were
2
transferred to a 25cm culture flask and 10 mis of medium 
added then the flasks were placed in a 37°C incubator. The 
cells were observed after one or two hours to ensure that 
they were adhering to the bottom of the flask. The next day 
the medium contaminated with the DMSO used in freezing was 
discarded and replaced with 5 mis of fresh growth medium.
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3.1.7 Culture vessels.
A number of different culture vessels were used;the size of 
vessel chosen depended on the number of cells required for an 
experiment and the number of replicates in which it was 
carried out. The smallest area for use if large numbers of 
replicates were required was a 2 cm x 2 cm square well of a 25
well plate. Next in size were 6 cm ambitubes and Lux 9 cm 8
2
well plates, then conventional tissue culture flasks of 25cm ,
2 2 75cm and 200cm .
3.1.8 Mycoplasma testing.
A washed sterile 22 x 22 mm glass coverslip was placed in a 
labelled well of a Lux multiplate for each line to be tested. 
One ml of cell suspension containing about 0.25 to 0.5 million 
cells was run onto each coverslip. The plate was then 
incubated at 37°C for 24 h . The medium was then removed
and the well washed with 2-3 ml of PBS which was discarded.
Two to three mis of Carnoy's fixative was then added to each 
well and left for 5 min. This was removed and the fixation 
repeated for an additional 10 mins. Coverslips were then air 
dried for 30 mins. The coverslips, along with a fixed 
infected control slide, were then stained for mycoplasma.
One ml of Hoechst 33258 stain solution was added to each well
and left for 30 mins at room temperature.
The stain was pipetted off and the coverslips washed in
distilled water. They were then blotted dry and a drop of
mycoplasma mounting medium placed on the upper cell covered 
surface. A labelled slide was then placed on top, pressed to 
expel excess solution and blotted dry. The edges of the
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coverslip were then sealed with clear nail polish.
Slides were examined in a Leitz fluorescence microscope under 
UV illumination. Cells were located with a x 12.5 objective 
and screened for mycoplasma with a x 100 oil objective.
The affected control slide was examined at the same time.
3.1.9 Control cell lines.
Normal control cell lines were acquired from the cell bank in 
the Department of Cytogenetics, Southmead Hospital, Bristol. 
Lines chosen were either those donated by apparently normal 
volunteers, or those referred to the Department of Cyto­
genetics for chromosomal analysis and found to be normal 
chromosomally. Samples referred for any sort of biochemical 
analysis or those from a patient with a history suggestive of 
a biochemical disorder were not included.
3.1.10 Maintainance Culture.
While cells were being grown in culture vessels, the medium 
was changed every Monday, Wednesday and Friday. The amount 
of medium used was approximately 0.2 ml per square cm of 
culture area. The medium was warmed to 37° before being 
added to the culture vessel.
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Section 3.2; Experiments on the Galactose Content of Cell
Culture Media
3.2.1 Estimation of the galactose content of cell culture 
media and sera by gas chromatography/mass spectrometry. 
Deproteinised, derivatised samples of cell culture media and 
sera were subjected to carbohydrate analysis by gas 
chromatography/mass spectrometry. The method used was based 
on that for the gas chromatographic measurement of blood and 
urine glucose and other monosaccharides by Murphy and Pennock 
(1972). Deproteinisation and derivatisation were carried out 
substantially as described in this reference. The conditions 
for chromatography were adapted from those for a packed column 
to those suitable for a capillary column, and flame ionisation 
detection replaced with mass spectrometric detection. For 
this, various experiments were carried out to discover the 
best ions to measure. The method used was as follows. 
Deproteinisation was carried out by the method of Somogyi as 
described in the reference, except that samples were not 
diluted with 3.4 ml of water. To 250/yl of the solution 
under test 50//1 of mannitol solution was added as an internal 
standard, followed by 500//1 of barium hydroxide solution. The 
mixture was vortexed and 500 //I of zinc sulphate solution 
added. The samples were vortexed, centrifuged at 3000 rpm for 
5 minutes then 500//1 of supernatant decanted. This was dried 
down in a glass conical tube at 70°C under a stream of 
nitrogen. Derivatisation was then carried out to form a 
methoxylamine acetylated derivative for gas chromatographic 
analysis. One hundred microlitres of methoxylamine in 
pyridine was added to each sample and after 15 minutes
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incubation at 30°C 100//1 of acetic anhydride was added and the 
incubation continued for a further 15 minutes. Derivatives 
were then taken to dryness under a stream of nitrogen, again 
at 30°C. One hundred microlitres of both chloroform and water 
were added to each sample, and after vortexing the aqueous 
layer was removed.
The conditions used for chromatography were: split ratio 50:1 
with one ml per minute of sample flow through column and 30mls 
per minute of carrier flow. Injection temperature was 230°C 
and detector 200°C. The column used was a Chrompack WCOT 12 
meter fused silica. The instrument was set up to record the 
total abundance of all ions between 100 and 600 atomic mass 
units and the abundance of a single designated ion, usually
187.0 amu. Mass spectra were recorded of all significant 
peaks, and single ions chosen on the basis of spectra content.
3.2.2 Determination of conditions for dialysis
Foetal calf serum was dialysed to remove uncombined galactose 
that it might contain. To establish the dialysis conditions 
which effectively removed galactose, 1/yl of radiolabelled 
galactose solution was added to 40 ml of foetal calf serum. 
This was sealed in a dialysis sack which was placed in 2L of 
saline. One ml of saline was removed every hour for 8 hrs, 
mixed with 20 ml of cocktail T scintillant and the 
radioactivity measured in a beta-counter.
3.2.3 Dialysis of serum
Conditions for routinely dialysing serum were established as a 
result of the experiments described in section 3.2.2. For
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routine dialysis, 40 ml of foetal calf serum were placed in a
dialysis sack and this was sealed and immersed in 2L of saline
for a minimum of 6 hrs and maintained at a temperature
of 4 degrees . The saline was then discarded and
replaced with 2L of fresh saline and dialysis continued for a 
minimum of a further 6 hrs. This was repeated once more to
give three changes of saline. The foetal calf serum was
removed from the sack, filter sterilised and stored at 4 
degrees centigrade until used, or for a maximum of 2 weeks.
3.2.4 Solid Phase Linked Lectins
Affinity chromatography with solid phase linked ricin lectin 
(SPLL) was used to separate proteins with exposed galactose 
residues from those lacking them. Columns of ricin lectin 
insolubulised on cross-linked 4% beaded agarose gel were used. 
An empty econo-column was filled with gel to a packed volume 
of 1 ml. One ml of the solution under test was gently run
onto the column and eluted with 1 ml aliquots of either 1 M
aqueous NaCl or 1 M aqueous NaCl containing 0.1 M galactose. 
The latter solution displaced compounds adhering to the column 
by their galactose residues, allowing them to be collected and 
the columns to be regenerated. All eluant was collected in 1 
ml aliquots. After use the columns were washed with 20 mis 
of 1 M aqueous NaCl to remove all galactose. When not in use 
the columns were filled with sufficient 1 M NaCl solution to 
cover the gel and stored at 4°C.
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3.2.5 Protein analysis - Folin and Ciocalteau.
Two variants of this method were used. In some experiments 
parameters were determined for populations of growing cells 
and related to the amount of protein present by solubilizing 
the cells in 0.1 M NaOH and measuring the amount of protein in 
this solution. For this protocol, standards of bovine serum 
albumin(BSA) were made up in the range 25 to 200 mg/1 and 
stored deep frozen. Solutions of 10 g/1 CuSO^ S ^ O  and 20 
g/1 sodium tartrate were made up, stored separately and equal 
volumes mixed immediately before use. One part of this 
solution was mixed with fifty parts of sodium carbonate (20g/l 
in 0.1 M NaOH) to form solution A. Folin and Ciocalteau 
reagent was diluted with an equal volume of water to form 
solution B. To 200 / j l  duplicates of sample, standard or blank 
(0.1 M NaOH) 1 ml of solution A was added, the solutions 
vortexed and left for 10 minutes at room temperature. Then 
0.1 ml of solution B was added and the mixture vortexed.
After a further 30 mins, the absorbance at 750 nm was measured 
in a spectrophotometer.
The second variant was used for measuring the protein content 
of solutions on which Western Blots were done. Standards 
between 100 and 500mg/l of BSA were made in SDS (10g/l) in 
aqueous NaCl (9g/l). For this protocol solution C consisted 
of lg/1 of CuSO^ 5H2O and 2g/L of sodium tartrate, and 
solution D of 8 g/1 of NaOH and 21.2 g/1 of Na2COg. Ten mis 
of sample were diluted with 190/vls of 1 g/1 SDS solution.
Fifty microlites of this dilution was added to 0.4 ml of 
solution C and 0.2 ml of solution D in duplicate, the mixture 
vortexed and incubated at room temperature for 10 minutes.
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Then 50/wl of a 1 in 5 dilution of Folin & Ciocalteau reagent 
were added, the mixture vortexed and incubated for 30 mins at 
room temperature, and the absorbance again determined at 750 
nm.
3.2.6 Protein Analysis Coumassie Brilliant Blue Dye Binding 
The method used was essentially that of Sedmak and Grossberg. 
The dye solution (60mg/l) was prepared in 0.6 M HCl, then 
filtered to remove undissolved material, and stored at room 
temperature. Standards of BSA were prepared in the range 25 
to 500mg/l in the same solution as test samples had been 
dissolved in. For the protein assay 500jul of dye solution was 
added to 500//1 duplicates of protein solution, mixed 
immediately and the absorbance at 620 nm determined against a 
1:1 mixture of blank and dye. In some assays the volume of 
protein solution was reduced to 250 or 125^1 if the protein 
had been dissolved in alkaline since this assay requires a 
strongly acid environment. Standard curves were run at 
various ratios of dye to protein solutions to establish which 
ratio produced the optimum standard curve.
3.2.7 Assays of epimerase in cultured cells
This assay was carried out on cell homogenates by the method 
of Gillett (1985). Cells growing in flasks were trysinised, 
a small aliquot was counted and the remaining suspension 
certrifuged. The supernatant was discarded and the cells 
resuspended in PBS and centrifuged again. This washing 
procedure was repeated twice more. After the final 
supernatant was discarded the cells were suspended in
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sufficient distilled water to give a count of approximately 
7
10 cells per ml. The suspension was frozen and thawed 3 
times by alternate immersion in liquid nitrogen and 37° water 
bath then centrifuged to remove cell wall debris. The 
supernatant was stored in liquid nitrogen until required for 
assay.
The epimerase assay was carried out in duplicate in small 
polythene test tubes. To each tube was added 10^ /1 of 6mM NAD, 
10/yl of water, 20//1 of buffer 10/yl cell lysate and 10/yl of 
radiolabelled UDP gal, 2mM, 1.2 //Ci/ml. The buffer was made 
from 4.5g glycine and 15.4 mg dithiothreitol brought to pH 8.9 
and made up to 100 ml with water. For determining the 
epimerase activity of serum, 10 jj 1 FCS was used in place of 
the lysate. The mixture was incubated for one hour at 37°C 
and for each duplicate a blank was run for which the lysate 
had been boiled to remove any enzyme activity. The reaction 
was stopped by placing the tubes in a boiling water bath for 2 
minutes. A polyethylene-immune cellulose plate was prepared 
by running in a chromatography tank containing a small amount 
of distilled water until the solvent front reached the top of 
the plate, then drying in a warm air oven. Five /j 1 of each 
reaction mixture were seeded on a 1cm line 1.5 cm above the 
bottom of the plate. The plate was then run in a solvent 
consisting of 13.8g of boric acid, 8.8 ml of tetramethylamine 
and 30ml ethanediol made up to 200ml with distilled water.
When the solvent front had almost reached the top of the 
plate, it was removed from the tank and dried. It was then 
scanned with the Berthold scanner to detect the UDPgal and 
UDPglu peaks. These were cut out, placed in a scintillation
vial, covered with scintillation fluid and the amount of 
radioactivity determined in a 3-counter.
Protein concentrations in the lysates were determined by the 
method of Folin and Ciocalteau and the epimerase activity 
expressed for each sample as n moles converted per mg of 
protein per hour.
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Section 3.3 - Normal Growth Rates of Cells
3.3.1 Determination of rates of incorporation of radio
labelled leucine, uridine and thymidine.
These experiments were carried out in 5x5 multiwell plates
2
with each well having an area of 4 cm . Cells were 
subcultured from normal culture vessels to multiwell plates 
and grown to a density of 25 to 50% of confluence as judged 
when examined by inverted microscope.
For experiments on the leucine incorporation rate, the medium 
in test wells was replaced with 0.5ml medium containing 1
3
/wei/ml of H leucine and the plate incubated at 37° for 1
hour. At the end of the incubation period medium was removed
from blank wells and replaced with medium containing labelled 
leucine. Medium was then quickly removed from all wells, 
each well washed four times with PBS and 200/vl of VT solution 
added to each well.
When the cells were rounded up, 100/t/l was removed from each 
well and run onto a fibreglass filter paper disc in a 
Millipore vacuum filtration system. The disc was washed by 
running 10ml of 10% (W/V) TCA in water through the system, 
followed by another 10ml of TCA solution and finally 10ml of 
IMS alcohol. The filter disc was removed, placed in an open 
scintillation vial and allowed to dry. Two ml of 
scintillation fluid were added to each vial and the 
radioactivity measured in a (3-counter. To determine the 
amount of protein in each well, 250/yl of 0.1 M NaOH was added
to the remaining 100>c/l of cell suspension. Duplicate
aliquots of 150 / j  1 of this mixture were removed for protein 
measurement by the Coumassie Brilliant Blue method.
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The resulting activity was expressed as counts per minute per
unit protein. For measurement of the uridine incorporation
3
rate, cell culture medium was supplemented with H uridine to 
a level of 1 jjC i per ml. The procedure was the same as for 
leucine, except that the cells were incubated for 6 hours at 
37° before the medium was removed.
Similarly, for thymidine incorporation, cell culture medium
3
was supplemented with H thymidine to 1 / u C i per ml, and cells 
were incubated in this medium for 24 hours, otherwise the 
protocol was the same as for leucine.
3.3.2. Comparative growth rates of cell lines.
These experiments measured the increase in cell numbers under
normal culture conditions for various cell lines. The lines
used were transferase deficient, epimerase deficient and
normal control human fibroblasts, and epimerase deficient and
normal control CHO cells.
2
A confluent 25cm flask was produced for each cell line used. 
Cells were removed from the flask surface with VT solution as 
described in section 3.1.3. Five mis of cell suspension was 
produced from each flask and this was plated out at a rate of 
0.2 ml in each of 25 wells of a multiwell plate, and the cells 
were incubated for 24 hours to allow recovery from 
trypsinisation and re-adhesion.
The cells in four wells were then counted by washing the wells 
with PBS, adding 200 ml of VT solution and counting 
the suspended cells in a modified Neubauer counting chamber as 
described in section 3.1.5. The counted cells were discarded, 
and the remaining wells were incubated further. Subsequent
71
quadruplicate counts were made after 48, 96 and 168 hours.
Section 3.4 - Growth Rates in Media With Added Galactose
3.4.1 Incubation of cells with Galactose.
A small flask of cells from each line under investigation was
grown almost to confluence. The cells were then trypsinised,
suspended in PBS and a small aliquot was counted. The
suspension was divided equally between wells of the multiwell
2plate to give about 25000 cells in each 4cm well. One ml of 
medium was then added to each well and the cells incubated for 
24 hours to allow them to adhere and recover from 
trypsinisation.
Medium supplemented with galactose to a level of ImM was then 
prepared by dissolving the appropriate amount of galactose in 
medium and filter sterilising. Five wells for each cell line 
were trypsinised with 200 //I of VT solution and the cells 
counted to give a value for the cell density at time zero.
The medium in all other wells was replaced with galactose 
supplemented medium. The medium was replaced every 2 or 3 
days as in normal maintenance cultures. After 24 hours, 6 
days and 10 days, a further five wells for each line were 
trypsinised and counted.
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3.4.2 Photography of cells incubated with galactose.
For each line under investigation a small flask of about 25% 
confluence was prepared. The medium in the flask was replaced 
with medium containing ImM galactose prepared as described in 
section 3.4.1. Photographs of the cells were taken using an 
inverted microscope with camera attachment on black and white 
film at the start of the experiment, and after 6 and 10 days 
growth in the galactose containing medium. The medium was 
replaced every 2 or 3 days as in normal maintainance culture.
3.4.3 Incubation of cells with radiolabelled galactose.
These experiments attempted to establish the rate of
14 14production of C labelled CC>2 from C labelled galactose.
Cells were incubated in a variety of media containing
different concentrations of glucose, galactose and other
additives and were incubated for a range of times.
The cell lines under test were grown in normal tissue culture
vessels then subcultured into Erlenmyer flasks containing
approximately 4ml of medium, and allowed to grow for at least
24 hours before incubation with labelled galactose was
started.
The media used were normal TC199 supplemented with foetal calf 
serum and glutamine, glucose free TC199 with foetal calf serum 
and glutamine in some experiments with galactose added to a 
concentration of 1 or 5mM, PBS and Krebs-Ringer buffer. The 
amount of radiolabelled galactose used were 0.05 and 0.1 //Ci 
per ml of culture medium. In some experiments lactic acid was 
added to the medium to a concentration of 0.7 mM. The period
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of incubation of labelled galactose ranged from 2 hours to 4 
days.
For each flask used a filter paper disc was prepared from 
Whatmans No 1 filter paper of the same diameter as the inside 
of the cap of the flask. One drop of concentrated NaOH was 
put on this and the disc placed inside the cap. The medium in 
the flask was discarded and replaced with the chosen medium 
containing radiolabelled galactose. Two mis of this medium 
were run in from a sterile pipette, taking care that no medium 
touched the neck of the flask. The flasks were then incubated 
at 37° for the length of the experiment. At the end of the 
experiment the caps were removed, 100 jj 1 of 1M HClO^ was run 
into each flask, the caps quickly replaced and the flasks left 
for 1 hour. The filter discs were then taken out, placed in 
scintillation vials containing 2ml of cocktail T scintillant 
and the radio-activity counted in a 0-counter. Blanks were 
run using Erlenmeyer flasks to which no cells had been added 
but which were treated the same. For some experiments cells 
were grown in the glucose-free medium supplemented with 5 mm 
galactose, for 24 hours before the experiment.
Section 3.5: Combined Galactose in Cells
3.5.1 Western Blot: Gel Electrophoresis.
The presence of exposed galactose residues in soluble 
fibroblast proteins was investigated by Western Blotting, i.e. 
solubilisation of cell proteins and gel electrophoresis 
followed by transfer of the electrophoresed protein to 
cellulose acetate and detection with a lectin/enzyme linked 
antilectin antibody system.
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Cell lines under investigation were grown to approximate
confluence in two large cell culture flasks. The cells were
trypsinised off, suspended in PBS and counted. The cells were
pelleted by centrifugation and the PBS decanted. Cells were
solubulised by the method of Anderson and Giehmberg (1978).
7
Approximately 10 cells per ml were dissolved in PBS 
containing 1% (w/v) Triton X-100 and 2mM phenylmethylsulphonyl 
fluoride at 4°C, and the mixture centrifuged at 3000g for 10 
minutes at 4°C. The supernatant was decanted and 50 //I 
removed for protein estimation by the method of Folin and 
Ciocalteau. The remainder of the supernatant was diluted with 
an equal volume of sample buffer containing 5% mercaptoethanol 
and stored deep frozen until required.
SDS - polyacrylamide gel electrophoresis was performed using 
the discontinuous buffer system of Laemmli (1970) with 
acrylamide concentrations of 3% (w/v) for the stacking gel and 
8% (w/v) for the separating gels. The gel size was 150mm x 
120mm x 1mm. Solubilised erythrocytes (150 /yg) duplicates in 
adjacent wells and molecular weight markers were 
electrophoresed for each experiment. Electrophoresis was 
carried out at 30V per slab for 16-24 hours, until the 
tracking dyes had almost reached the bottom of the gel.
Western Blotting - electrotransfer.
This procedure was performed essentially according to the 
method of Towbin (1979). The SDS gel was removed from its 
glass plates and a piece of cellose nitrate paper cut to the 
same size as the gel placed on top. A sandwich was formed 
consisting of one piece of Scotchbrite and 2 pieces of filter 
paper both soaked in transfer buffer on either side of the gel
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and this was placed in a transfer cassette. This was then 
placed in a transfer tank and electrophoresed in a plane and 
perpendicular to the sandwich for 20 hours at 250 mA and 4°C. 
After transfer, the gel and paper were separated. The gel was 
fixed in 250 mis of 50% methanol, stained for 30 mins with 
Coumassie Brilliant Blue (CBB) then destained with 
GAA/methanol/water destaining solution. The nitrocellulose 
membrane was cut into strips (16 x 130 mm) corresponding to 
the gel slots. Protein on the molecular weight strips was 
visualised by staining with amido black solution, then 
destained with the same solution as was used for CBB. 
Non-specific protein binding on the nitrocellulose was blocked 
by soaking the strips in skimmed milk powder solution (5g in 
100 mis of PBS/tween) for 30 mins. then rinsing 3 times with 
PBS. The pairs of strips for each sample were divided into a 
test strips and a control strips and each set placed in a 
shallow plastic tray. For detection of galactose in the 
membrane bound proteins, the test strips were incubated with 
galactose specific lectin (control strips with lectin plus 
galactose), then all strips were incubated with rabbit 
anti-lectin antibody followed by peroxidase-linked anti-rabbit 
antibody plus a chromogen producing colour development at the 
site of lectin binding. Specifically, test strips were 
incubated for 1 hour at room temperature with 5ml of PBS/tween 
containing 75 ml of lectin concentrate, control strips were 
incubated under the same conditions with 5ml of lectin and 
PBS/tween solution to which galactose had been added to a 
concentration of 0.3M.
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Test strips were washed three times with 50ml of PBS and 
control strips with 50ml of PBS/galactose. Each set of strips 
was then incubated with 7.5ml anti ricin antibody in PBS plus 
milk powder for 1 hour. The antibody solution was removed and 
strips washed 6 times in PBS with a 5 minute soak for every
wash. Each set of strips was then incubated with 5ml of
peroxidase-conjugated swine anti-rabbit antibody in PBS plus 
skimmed milk powder for 1 hour. The antibody was decanted and
the strips washed 6 times in PBS as before.
Antibody binding was revealed by incubating the strips with 
diaminobenzidine in PBS containing 0.02% (v/v) hydrogen 
peroxide until bands became visible (between 10 seconds and 1 
minute). The reaction was terminated by washing the membranes 
for 5 minutes in distilled water. Membranes were then dried 
on filter paper and stored in the dark.
Upon completion of the experiment, membranes and the 
polyacrylamide gel were photographed by the Medical 
Photography Department, Southmead Hospital.
3.5.2 - Staining Cells with Fluorescein Isothyocyanate-linked 
Lectin.
Fluorescein isothiocyanate (FITC) linked ricin is a sensitive 
and specific stain for exposed galactose residues. It was 
used in this experiment to stain a range of living cells. 
Sterile, acid washed coverslips (22 x 22 mm) were placed in 
each well of an 8-well plate. A suspension containing
5
approximately 10 cells in 1 ml of medium was run onto the 
coverslips aid the cells incubated for 24 hours, on a slight 
incline to give a range of cell densities across the slide.
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Coverslips were removed from the wells, washed three times 
with 2ml of PBS then each coverslip was cut in half with a 
diamond tipped scriber. The two halves were put in separate 
wells of a multiwell plate. Two hundred microlitres of 
fluoroscein-linked lectin solution (50 /yg per ml in PBS with 
trypan blue) were run onto one half of each coverslip and 200 
/ j 1 of lectin solutions plus galactose (50 mM) onto the other. 
The coverslips were incubated for 30 mins then the lectin 
containing solution removed and each well washed 5 times with 
10 ml of PBS. Coverslips were mounted cell surface downwards 
on glass slides with a drop of PBS and the edges sealed with 
clear nail polish. Slides were examined immediately under 
phase contrast and UV illumination using x25 and x40 
objectives. The slides were photographed using the camera 
attachment for the microscope under phase contrast and UV 
illumination by automatic exposure with spot metering centred 
on a fluoresing cell. The results of visual examination were 
also recorded as the presence or absence of fluorescence 
together with an estimation of the relative degrees of 
staining of similar cell lines.
3.5.3 - Quantitation of Fluorescein Isothyocyanate Binding by 
Fluorimeter.
For each cell line under investigation a twenty-five well
plate was used. Cells were grown in medium containing
dialysed serum, medium made with non-dialysed serum or medium
supplemented with galactose, for 2 weeks before the
experiment. Between 50, 000 and 200,000 cells in 200 jjI of
2
medium were put in each 4cm well, giving a range of cell
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densities in each plate, and the plates were incubated for 24 
hours to allow the cells to adhere and recover from 
trypsinisation. The medium was removed and the wells rinsed 3 
times with 2ml of PBS. To 20 of the wells on each plate, 1 ml 
of PBS containing FITC linked lectin (20 ng lectin protein/ml) 
was added. The other 5 wells were designated blanks, and to 
these 1 ml of lectin in PBS plus galactose (50 mM) was added. 
The plate was incubated for 30 minutes at room temperature 
then the lectin containing solutions removed and each well 
washed 5 times with 5ml of PBS. One ml of 0.1 M NaOH was 
added to each well to dissolve the cells. Four hundred 
microlitres were removed and used for protein estimation by 
the Commassie Brilliant Blue method. One ml of water was 
added to each well, the contents removed and placed in a 
fluorimeter cell. In some experiments the cells were counted 
before being dissolved in NaOH. For this, 200 jj 1 of VT 
solution were added to each well, the cell count determined by 
used of a counting chamber, then 1 ml of 0.1 M NaOH added to 
each well, and the contents of the well placed in a 
fluorimeter cell.
The fluorescence was determined in the Shimadzu fluorimeter. 
The settings used were: excitation wavelength 495 nm, 
(bandwidth 3nm), emission wavelength 515 nm, (bandwidth 5nm) 
and averaging time 1 sec. The instrument was set to zero with 
0.1 M NaOH in the fluorimeter cell then the gain adjusted to 
give a reading of 50 units when the fluorescence standard was 
placed in the cell. Initially, a sample was scanned over a 
range of excitation and emission wavelengths to confirm the
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choice of wavelengths. Samples were then read, with the blank 
and standard being checked frequently to avoid instrumental 
drift.
The fluorescence per unit protein or per 1000 cells was then 
determined.
3.5.4 - Determination of carbohydrate composition of cells by 
gas chromatography.
The concentrations of a number of monosaccharides were 
determined in hydrolysates of whole cells. This was done by 
gas chromatography using the method of Bhatti, Chambers and 
Clamp (1970).
Cells were grown for three subcultures in media containing 
dialysed serum or undialysed serum, or medium supplemented 
with galactose to 1 or 5 mM. Each cell line under 
investigation was grown to confluence in a large flask using 
the chosen medium. The medium was removed and the flask 
rinsed three times with PBS. The cells were trypsinised off 
with 15ml of VT, spun down and resuspended in 1 ml of PBS. 
Aliquots of 500/yl of this suspension transferred to small 
glass ampoules. These were centrifuged at 3000 rpm for 5 
minutes and the supernatant decanted, 0.5ml of water was then 
added to each ampoule and they were vortex mixed. Fifty y l  
was removed for protein analysis by the Coumassie Brilliant 
Blue method and the remainder was frozen in liquid nitrogen 
then lyophilised.
The technique for gas chromatography were as described in the 
reference (Bhatti 1970). In essence 0.5 ml of methanolic HCl 
(1.5 M ) and mannitol as an internal standard were added to
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each ampoule. They were sealed and incubated at 90°C for 24 
hrs, after which the acid was neutralised by the addition of 
solid silver carbonate. The supernatant was transferred to a 
pear shaped flask and evaporated under reduced pressure.
Acetic anhydride (0.1ml) was added and the flasks incubated at 
room temperature for a minimum of 6 hrs. Silylating reagent 
(50//1) was added and the flasks left for 30 mins. After 
centrifugation, 1-5//1 of supernatant was injected into the gas 
chromatograph. An SE 30 column was used with a temperature 
programme of 140°C to 200°C at 0.5°C/minute. Amounts of 
monosaccharides in the sample were calculated by integration 
of sample and internal standard peaks and the amounts of 
monosaccharides per unit protein were calculated from peak 






All cell lines chosen including those from patients with 
inherited metabolic diseases were successfully cultured, grew 
at adequate rates and were able to progress to confluent 
growth under the culture conditions described.
4.1.2 Infection
Two episodes of bacterial infection of culture medium 
occurred during this work. Both were immediately obvious: 
the excess metabolic activity of the bacteria caused the pH 
indicator in the TC199 medium to become bright yellow, 
showing an abnormally low pH, and bacteria were visible on 
microscopy. Contaminated cultures were discarded.
4.1.3 Mycoplasma Testing.
No intracellular fluorescence was observed on any slide 
prepared from cells cultured during the project. The fixed 
infected control slides showed punctate intracellular 
fluorescence on all occasions that the test was carried out. 
These results suggest that all cultures remained mycoplasma 
free for the period of experimentation.
4.1.4 Cryopreservation.
Recovery of frozen cells from liquid nitrogen storage 
produced live cells capable of adhesion and division on all 
occasions.
4.1.5 Karyotypes.
All human fibroblast lines had diploid chromosomes which were 
normal in number and visible structure on microscopy, and 
which were appropriate for the sex of their origin. This 
normality was preserved when the epimerase deficient cell 
line was tested during and at the end of the experimental 
period.
4.1.6 Confirmation of enzyme deficiencies in stock cells. 
The results of the fibroblast enzyme assays were:-
Transferase assay:
Transferase deficient line 1 : no detectable activity
line 2 : no detectable activity
line 3 : no detectable activity
Epimerase assay:
Epimerase deficient line : no detectable activity
The batch of foetal calf serum used throughout this period
was also assayed for epimerase activity. No  detectable
activity was found.
Enzyme deficiencies in supplied cells:
Three externally supplied cell lines were used in 
experiments, these were the wild type and epimerase deficient 
CHO cell lines, and ED2 a human fibroblast line from the case 
of generalised epimerase deficiency described by Garibaldi et 
al(1983 ) .
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4.1.7 Cell Culture: Discussion.
As part of this project, facilities to culture cells were 
established, and fibroblast and Chinese hamster ovary cell 
cultured reproducibly and reliably. Vigilance for infection 
was considered to be especially important in these experiments 
since the lines being studied carried particular genetic 
characteristics and the introduction of any exogenous DNA was 
a possible source of error. Bacterial infection is probably 
the least likely to confound, since infection is generally 
obvious both macro- and microscopically as described in 
section 4.2.1, and bacteria do not generally enter the cells. 
In contrast, mycoplasma infection is more serious. Cultures 
may be affected in two ways: as an intracellular parasite
mycoplasma slows down the growth of infected cells and would 
therefore affect several of the parameters observed in these 
experiments, such as rate of increase in cell number or rate 
of protein synthesis. Secondly, they bring new genetic 
material and possibly the missing enzyme into a deficient 
cell. Mycoplasma are notorious for persisting in cultures,
85
spreading between cultures in one laboratory, and being 
difficult to eradicate. Therefore, the frequent checks made 
for the presence of mycoplasma with negative results suggest 
that mycoplasma were not at any time present in cultures.
Infections.
Viral infections are not considered to be such a problem in 
fibroblast culture since significant infection is rare and 
usually leads to death of the culture rather than a persisting 
but altered culture. Interestingly, in 1971, transferase 
deficient fibroblasts were used in an early experiment in 
molecular biology (Merrill 1971). They were infected with a 
bacteriophage virus which carried a bacterial transferase 
gene. This induced the deficient fibroblasts to synthesise 
transferase. The infecting virus was of course formed for the 
experiment and was not naturally occurring. In the experience 
of the laboratory where this work was carried out a line 
tested as transferase deficient has never subsequently 
acquired activity spontaneously and a search of the literature 
produced no reports of similar cases.
Karyotypes:
Karyotypes were observed to be constant throughout the series 
of experiments. Changes in karyotype during culture are 
recognised as possible. Although such a change would not 
introduce new material it could affect parameters such as the 
rate of cell division. Passage numbers were therefore kept 




The enzyme measurements on all cells acquired from stocks at 
Southmead Hospital confirmed the expected deficiencies of 
transferase in lines TD 1, 2 and 3, and of epimerase in EDI.
It was also important to confirm that there was no detectable 
epimerase activity in the batch of foetal calf serum used for 
these experiments. Epimerase is normally located 
intracellularly but foetal calf serum is a natural product 
containing many enzymes and proteins, and it is possible that 
it could contain products of lysed cells, especially 
erythrocytes (epimerase is present in erythrocytes). Cells in 
culture are able to endocytose complete proteins and enzymes 
from culture media (Willingham 1985) so it was necessary to 
establish that there was no measurable activity of epimerase 
in the serum used, and this was found to be the case.
The cell line ED2 was supplied by Garibaldi et al as coming 
from their case described in the Journal of Pedriatrics as 
generalised epimerase deficiency (Garibaldi 1983). However, 
the epimerase activity (Section 4.1.6) was found to be rather 
higher than the control fibroblasts. This was communicated to 
Dr. Garibaldi. Further assessment at Southmead Hospital 
showed this cell line to be transferase deficient. Garibaldi 
et al then published a further letter (Garibaldi 1986) saying 
that "We have recently become aware that a basic error exists 
in our paper describing a case of epimerase deficiency". He 
describes the results found as part of this thesis and states 
that a fresh sample obtained from the index case confirmed 
that this patient had transferase deficiency galactosaemia.
He says he has no explanation for the initial results and
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apologises for the erroneous information.
No detectable activity was found in the line EDI, the case 
detected locally. This confirms other work done on this line 
(Holton 1981, Gillett 1985) who were unable to find any 
measurable activity. However Kingsley (1986) claims that 
analysis of this line showed measurable activity of 9 
nmol/mg/hr compared to 509 nmol/mg/hr for the single normal 
line measured. The paper states that the enzyme activity was 
determined with a thin layer chromatography assay and gives a 
reference to a paper entitled "Reversible defects in O-linked 
glycosylation and LDL receptor expression in a 
UDP-Gal/UDPGalNAc 4 - epimerase deficient mutant", which was 
in press. The analytical technique which allows 1.8% of 
activity to be discriminated from zero is therefore not 
described, so it is not possible to reconcile the discrepancy 
between this paper and the other three results. As Kingsley 
states in this paper, and others agree (Pillert 1983) one 
enzyme is responsible for epimerisation of both UDPGal and UDP 
N-acetyl-galactosamine (UDPGal N-Ac). It is, therefore, 
difficult to explain how the cell line EDI had 1.8% of control 
activity for UDPGal but 11.6% of control activity for UDPGal 
N-Ac, if the assay is reproducible at these low levels. The 
paper by Kingsley also states that the clone of CHO cells had 
zero activity. This clone supplied by Kingsley et al 
was used in subsequent experiments in this work.
Asymptomatic cases of erythrocyte and leucocyte epimerase 
deficiency have been detected in screening programs as 
described in the introduction. Examination of fibroblasts 
from 8 such cases showed that all had detectable epimerase
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activity (Gitzelmann 1978).
Similarly, activity could be stimulated by phytohaemagglutinin 
in 6 out of 7 deficient leucocyte lines (Mitchell 1975).
These patients did not have generalised epimerase deficiency 
(Gitzelmann 1980), in contrast to the index case which was the 
origin of cell line EDI (Holton 1981).
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4.2 Experiments on the Galactose Content of Cell Culture
Media.
4.2.1 Gas chromatographic analysis with mass spectrometric 
detection.
For the initial experiments lmmol/L solutions of galactose and 
glucose in water with mannitol as an internal standard were 
used. The galactose solution produced two peaks at 10.3 and
12.4 minutes retention time (figure 1) and the glucose 
solution, two partially resolved peaks at 13.4 and 13.6 
minutes retention (figure^2). Mass spectra of the larger 
galactose peak showed that the most suitable ions for single 
ion monitoring were 187, 226.1 and 331.1 atomic mass units 
(amu).
Galactose was added to TC 199 liquid medium to final 
concentrations of 0.1, 1, 10 and 100 //mol/L and derivatives 
prepared of these solutions. GC-MS analysis of these 
derivatives with selective ion monitoring at the most abundant 
ion (187) is shown in figures 3 to 6. Samples of TC 199 
medium without any added galactose and of the batch of foetal 
calf serum used throughout these experiments were also 
analysed (figures 7 and 8).
Spectra of the 10 and 100/wmol/L solutions show large peaks in 
the position of galactose. The lumol/L solution has two 
small peaks at the appropriate retention times. The 0.1 
/wmol/L solution and TC199 medium did not show any significant 
peaks in the position of galactose. The spectrum of foetal 
calf serum was more complicated and had several peaks 
including one coincident with the slower-running galactose 
peak (figure 8). Co-injection of the serum sample with a
90
galactose standard (figure 9) confirmed the expected position 
of peaks in a serum sample.
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Figure 1. Gas chromatography with mass spectrometric 
detection of a 1 mmol/L solution of galactose using mannitol 
as an internal standard. The traces show total ions from 100 
to 600 atomic mass units (amu) on the left hand and selective 
monitoring of ion 187.0 amu in the right hand trace.
Retention times (RT) are shown in minutes and relative 
abundances (ABUND) on an arbitrary scale. Two well separated 
peaks are produced by galactose.
Mannitol
Figure 2. Gas chromatography with mass spectrometric 
detection of a 1 mmol/L solution of glucose using mannitol as 
an internal standard. Total ion monitoring of all ions from 
100 to 600 amu is shown in the left hand trace, and selective 
ion monitoring of ion 187.0 on the right. Two partially 
resolved peaks are produced by glucose.
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STOPPED AT RETENTION TIME 17.39
Figure 3. Gas chromatography with mass spectrometric 
detection using the single ion 187.0 amu of a solution of TC 




Figure 4. Gas chromatography with mass spectrometric 
detection using the single ion 187.0 amu of a solution of 
TC 199 medium with galactose added to a concentration of 
10 /ymol/L.
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STOPPED AT RETENTION TIME 17.89
Figure 5. Gas chromatography with mass spectrometric 
detection using the single ion 187.0 amu of a solution of TC 
199 medium with galactose added to a concentration of 
1 //mol/L.
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STOPPED AT RETENTION TIME 17.88
Figure 6. Gas chromatography with mass spectrometric 
detection using the single ion 187.0 amu of a solution of TC 
199 medium with galactose added to a concentration of 
0.1 /ymol/L.
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STOPPED AT RETENTION TIME 17.64
Figure 7. Gas chromatography with mass spectrometric 
detection using the single ion 187.0 of TC 199 medium.
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STOPPED AT RETENTION TINE 14.99
Figure 8. Gas chromatography with mass spectrometric 
detection using the single ion 187.0 of the batch of foetal 
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STOPPED AT RETENTION TIME 17.90
Figure 9. The sample shown in figure 8 was co-injected with 
a derivatised galactose solution. This confirms the expected 
position of the two galactose peaks.
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4.2.2 Galactose containing glycoproteins in foetal calf serum.
In these experiments one ml of foetal calf serum was placed on 
columns of immobilised ricin lectin and eluted with 1 M NaCl 
solution to remove unbound protein, and 1 M NaCl with 100 mM 
galactose, which displaced proteins bound by their galactose 
residues. Eluates were collected in one ml fractions.
Elution with ten mis of NaCl solution followed by 7 mis of the
galactose containing solution produced the protein levels 
shown in Table 2 and graphically in figure 10.
Of the 35.9 mg of protein 35.66 mg (99.3%) came out in the 
first four fractions. A subsiduary peak totalling 119 /jg 
(0.33% of the total protein) was also evident, and this was 
eluted as soon as the galactose containing solution was placed 
on the columns. These results are compatable with the 
retention by the column of proteins in foetal calf serum which
have exposed galactosyl residues. However it is also
possible that the second peak represented a chromatographic 
retention of a proportion of the protein by some other 
property, and that its elution when galactose containing 
eluant was used was coincidental. To test this hypothesis, in 
the next experiment 14 mis of 1M NaCl were used (instead of 10 
mis) before elution with the galactose containing solution 
(figure 11). Once again a small second peak was liberated 
immediately on changing eluants.
Next the completeness of removal of the proteins which the 
column was binding was investigated by running the same sample 
through the column three times. One ml of foetal calf serum 
was run through as described in the first experiment of this 
type. The column was regenerated and fractions 1 to 4 placed
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on the column again, and eluted with 7 mis of 1 M NaCl 
followed by 5 mis of NaCl plus galactose. The first five 
fractions were placed on a regenerated column and eluted with 
5 mis of NaCl and 5 mis of NaCl plus galactose. A second peak 
was present on each pass, but it became progressively smaller. 
The amounts of protein in each fraction of the second peak for 
the three runs are shown in figure 12, and the total amounts 
of protein in each of the three peaks in figure 13.
Since removal of proteins which bound to the column was 
clearly not complete on each run, it was possible that this 
amount of foetal calf serum overloaded the binding sites 
available. This was tested by increasing the volume of serum 
placed on the column and investigating whether the amount of 
protein bound increased proportionately. Doubling the amount 
of serum placed on the column resulted in an increase in the 
size of the second peak from 109 to 160 mg of protein.












































F igure  10. E lu tion  of Proteins from  
FITC Colum ns w ith  1 m o la r NaCl.




100 m m o l /L  galactose 





1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Fract ion n u m b e r
Figure 10. Affinity chromatography of proteins with exposed 
galactose residues. One ml of foetal calf serum was placed in a 
solid phase linked lectin column and 1 ml fractions collected as it 
was eluted, first with 1 mol/L NaCl solution to remove most proteins 
(fractions 1 to 10). Proteins bound to the column were displaced by 
eluting with 1 mol/L NaCl with 100 mmol/L galactose, producing a 
second peak of proteins bound by their galactose residues.
Figure 11. E lu tion  ol Proteins from  
FITC Colum ns w ith  1 m o la r NaCl.





100 m m o l /L  galactose 






1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Fract ion n u m b e r
Figure 11. Affinity chromatography of proteins with exposed 
galactose residues. The experiment shown in figure 10 was repeated 
except that 14 mis of the first eluant were used. The second peak 
was once again not evident until a galactose containing eluant was 
used. This confirms an affinity effect of proteins bound by 
galactose residues.
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Figure 12. G alactoprote in  Peak- Repeated 







Protein (m g /L )
12 13 14
Fract ion n u m b e r
Third pass Second pass First pass
Figure 12. The completeness of removal of galactoproteins by solid 
phase linked lectin columns was examined by putting an aliquot of 
serum down a column three times and measuring the decreasing size of 
the galactoprotein peak with each passage. The peak was diminished 
with each passage, but not completely removed.
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Figure 13. Total Protein on 
1st, 2nd and 3rd pass







N u m b e r  ot passes
Figure 13. This shows the total amount of protein in fractions 





4.2.3 Dialysis of Serum.
This experiment investigated the conditions required for 
removal of uncombined galactose from foetal calf serum by 
dialysis. Radiolabelled galactose was added to foetal calf 
serum and the rate of increase of radioactivity in the 
dialysate measured. The results are shown in figure 14. This 
shows that over 90% of the dialysable radioactivity was 
removed in 5 hours.
4.2.4 Section 2 - Galactose Content of Culture Media: 
Discussion.
Much of the experimental content of this thesis concerns cell 
lines which are deficient in the enzymes of galactose 
metabolism, including two which are ostensibly unable to 
synthesise glactose at all. It is, therefore, essential to 
know as accurately as possible what the galactose content of 
the culture medium is, if results of experiments on the 
galactose content of cells are to be interpretable. 
Surprisingly, other workers have not considered this in the 
culture of epimerase deficient fibroblasts and CHO cells 
(Kingsley 1986) or transferase deficient fibroblasts in media 
described as galactose free or galactose supplemented (eg: 
Pourci 1990, Beratis 1987, Miller 1968).
In particular Kingsley suggests that the CHO clone used in his 
(and this) work is totally epimerase deficient and therefore 
cannot synthesise sufficient glycoprotein for structional 
requirements and as a consequence expresses very low levels of 
LDL receptors (less than 5 per cent).
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F igure  14. Removal of Galactose from  
Serum by D ialysis






Dialysis t im e  (hrs)
Figure 14. One microlitre of radiolabelled galactose solution was 
added to 40 mis of foetal calf serum and the mixture dialysed 
against 2 litres of normal saline at 4°C. Samples were removed from 
the dialysis medium at the times indicated and the activity 
remaining in the sac calculated.
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Normal culture medium for fibroblasts consists of a buffered 
mixture of glucose and amino acids in water, supplemented with 
foetal calf serum. The serum component is the least defined 
and least controllable in terms of its contents. Attempts 
have been made to culture cells without any serum although 
this is more successful with transformed cell lines than 
normal fibroblasts (Evans 1964). Ultroser, a product marketed 
as a serum replacement is according to its manufacturers 
literature, partially derived from foetal calf serum.
The technique of gas chromatography with mass selective 
detection was chosen because established methods existed for 
the gas chromatography of monosaccharides, and these could be 
used with a detection system that is highly sensitive, and by 
monitoring spectra of peaks and choosing appropriate ions, it 
is also specific so that the desired analyte may be detected 
even under the peak of another substance.
Two peaks were produced by galactose. These are not anomers, 
as are often found in sugar derivitisation, since the aldehyde 
group was also derivitised, locking the sugar in the 







The results also show that galactose can be detected by this ' 
method to low micromolar levels. A 10//mol/L solution produced 
significant peaks and a 1/ymol/L ambiguous ones, suggesting a 
limit of detection of approximately 3/>mol/L. No free 
galactose was detected in TC 199 medium or in the batch of 
foetal calf serum used throughout these experiments but peaks 
were easily discernible in spiked samples.
The next experiment in this section used columns of solid 
phase linked ricin lectin. There were two aims to these 
experiments: to demonstrate that the serum used contained
proteins with exposed galactose residues, and to investigate 
the potential for using these columns to produce serum free of 
such proteins. Tsao (1981) investigated the binding of 
labelled cell surface glycoconjugates to columns of solid 
phase linked ricin lectin and showed that all labelled 
glycoproteins were bound to the column but glycolipids 
containing terminal galactosyl or N-acetylgalactosaminyl 
residues did not bind. The lipids probably failed to bind 
because they had only a single galactosyl residue by which to 
adhere, unlike the multiple bonding of glycoproteins.
The results of these experiments show that a proportion of the 
serum protein is retained on the column (fig.10), and that 
these proteins are displaced by the addition of galactose to 
the eluent. The hypothesis that galactose is displacing these 
proteins and that they are not simply retained 
chromatographically and elute co-incidentally with the change 
in solvent is confirmed by increasing the amount of the first 
eluent used: once again proteins are displaced by the addition 
of galactose (fig.11).
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The next experiment assessed the completeness of removal 
(fig.12). The four galactoprotein containing fractions 
(10-14) were collected and put down the column once more, 
collected again and run through the column a third time.
Each time fractions 10 to 14 gave decreasing amounts of 
glycoprotein as will be seen from figure 13 which shows the 
glycoprotein in fractions 10 to 14 for each run. This shows 
that after three passages, fractions 10 to 14 still produced a 
solution containing 60mg/L of glycoprotein, compared to 
162mg/L on the first passage, although it was also 
demonstrated that the binding sites on the column were not 
fully saturated by increasing the amount of serum used. It 
is, therefore, clear that while the columns significantly 
reduce the amount of glycoprotein with exposed galactosyl 
residues, to produce a serum that gives no measurable second 
peak at all would take a very large number of passages.
The experiments on the dialysis of labelled galactose showed 
that free galactose could be dialysed out of serum under the 
conditions described, and would be equilibrated in about 12hrs 
(fig.14). As a result of this, dialysed serum was 
subsequently produced by allowing equilibration overnight. 
Three periods of dialysis using the volumes described will
5
lower the galactose concentration by a factor of 10 . The 
GC-MS analysis of media showed a galactose concentration 
significantly below 10//mol/L, therefore the concentration of 
free galactose in dialysed serum would be below 
1OOpicomoles/L.
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4.3 Experiments on cell growth rates in normal media.
These experiments investigated the rate at which cells with 
enzyme deficiencies grew in comparison with control 
fibroblasts in normal culture medium, that is with no added 
galactose. Four measures of cell growth were assessed 
independently. These were the increase in cell number, the 
rate of radiolabelled leucine incorporation which reflects the 
rate of protein synthesis in the cell, and the rates of 
radiolabelled uridine and thymidine uptake showing 
respectively the rates of RNA and DNA synthesis by the cells.
4.3.1 Cell Numbers.
These were assessed at four points over 7 days. Measurements 
were made on three control fibroblast lines, three transferase 
deficient lines and one epimerase deficient line, and on the 
epimerase deficient and control CHO cell lines. For all cell 
lines, each measurement was made in quadruplicate and the 
results are plotted in figure 15 for fibroblasts and figure 16 
for CHO cells. Figure 15 shows that normal and transferase 
deficient cells increase in number at similar rates, but that 
the epimerase deficient line increases at a significantly 
slower rate. In contrast, Figure 16 shows that epimerase 
deficient CHO cells increase at very similar rates to control 
CHO cells.
4.3.2 Protein Synthesis Rates.
These experiments were carried out in two groups. In the 
first, two normal controls, two transferase deficient lines 
and one epimerase deficient fibroblast line were used, and
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Figure 15. Growth ot F ibroblasts in  
Galactose-Free M ed ium .
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NCI NC4 +  NC8 Q EDI
TD1 TD2 TD3
Figure 15. The growth of three normal control (NC) lines, three 
transferase deficient (TD) and one epimerase deficient line (EDI) in 
normal medium was jnvestigated. A suspension of each cell line was 
placed in 16 4 cm wells of a multiwell plate and left for 24hrs to 
allow adhesion. Four wells were then trypsinised and the cells 
counted (time 0). Further quadruplet counts were made at 2, 4 and 7 
days.
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Figure 16. G rowth ot CHO Cells in  
Galactose-Free M ed ium .
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CHO w i l d  ■+ CHO c lone
Figure 16. The growth of CHO wild type and epimerase deficient 
clone cells in normal medium was examined. The conditions were the 
same as in figure 15.
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these results are shown in figure 17. In the second, three 
transferase deficient lines, one normal control and one 
epimerase deficient line, were used (fig 18). Measurements 
were made in triplicate, the highest, lowest and mean are 
shown.
Results were calculated by subtracting a blank value (from 
wells which had radiolabelled medium added at the end of the 
experiment) from the counts observed in 300 seconds for the 
test wells and dividing this by the amount of protein present 
per well. Results were normalised to the epimerase deficient 
line equaling 100 in order to show by what extent other lines 
synthesised protein at faster or slower rates. It is evident 
that the transferase and epimerase deficient lines do not 
incorporate leucine at a significantly different rate from 
control cell lines.
4.3.3 Uridine Incorporation Rate.
This experiment was carried out on four normal control 
fibroblast lines, three transferase deficient and one 
epimerase deficient line, and the wild type and epimerase 
deficient CHO cell lines. Four observations were made on each 
cell line : these are shown, together with the mean and 
standard deviation in Figure 19. The maximum percentage of 
the label incorporated in any one well in the fibroblast lines 
was 3.9% by the transferase deficient line TD2, and 6.2% in 
the epimerase deficient CHO cell line. The results show that 
the epimerase deficient fibroblast line incorporated uridine 
at a comparable rate to control fibroblasts, but transferase 
deficient lines had a significantly higher rate. There was
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Figure 17. Normal control, epimerase deficient and transferase 
deficients cells were grown in multiwell plates. The medium was 
removed from test wells and replaced with medium containing 1 pCi/ml 
of H leucine. After lhr medium in blank wells was removed, 
replaced with the radiolabelled medium then all wells washed. The 
radioactivity incorporated and protein per well were then estimated 
by ^-counting as described in the text. The incorporation per unit 
protein was expressed as a percentage of that for cell line EDI.
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Figure 18. Leucine incorporation rates were examined for further 
cell lines as described in figure 17.
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Figure 19. U r id in e  In co rp o ra tio n  Rates
1400 
12 0 0  
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controls I ep im erase  def ic ient
transferase
def ic ient
C Z 3 CHO cells
A c t iv i t y  ( c p m /p g  pro te in )
NCI NC4 NC8 NC12 EDI TD1 TD2 TD3 W i ld C lo n e
Cell  l in e
Figure 19. Uridine uptake was assessed by a similar method to that 
described in figure 17, except that medium containing lyCi/ml of H 
uridine was used. Results are expressed as counts minute per yg of 
proteins.
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no significant difference between the two CHO lines.
4.3.4 Thymidine incorporation rate.
This was assessed in the same cell lines as were used in 
experiment 4.3.3 : Uridine Incorporation Rate. The experiment 
was carried out and results calculated the same way as in the 
previous experiment, except that radiolabelled thymidine 
replaced uridine. The results are shown in figure 20. As 
with experiment 4.3.3 the epimerase deficient fibroblasts are 
not significantly different from control fibroblasts but 
transferase deficient lines had a higher average incorporation 
rate than controls. Again, there was no significant 
difference between epimerase deficient and wild type CHO 
cells.
4.3.5 Section 3: Cell growth in Normal Media - Discussion.
These experiments were carried out in media to which no 
galactose had been added: that is medium which in Section 2 
was shown to contain less than one nanomole per litre of free 
galactose but which did contain glycoprotein with exposed 
galactosyl residues. It is important to note however that 
this does not mean that the metabolism in transferase 
deficient cell lines will be normal. In vivo galactosaemic 
subjects will have significant levels of gal-l-P in 
erythrocytes despite a galactose-free diet and in vitro 
galactosaemic erythrocytes accumulate gal-l-P when incubated 
with glucose (Gitzelmann 1980), and galactosaemic fibroblasts 
do likewise (Pourci 1990).
The simplest and most important observation from the
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Figure 20. T h y m id in e  In co rp o ra tio n  Rates
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Figure 20. Thymidine uptake was assessed as in figure 17 except 
that medium containing lyCi/ml of H thymidine was used. Results 
are expressed as counts per minute per yg of protein.
^765
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experiments on cell number is that both transferase and 
epimerase deficient cell lines increased in number when 
cultured with glucose as their carbohydrate source.
Transferase deficient fibroblasts have been shown to grow in 
culture previously (Krooth 1960, Pourci 1990) but have not 
been quantitatively compared with control fibroblasts. The 
results in Figure 15 show no difference between transferase 
deficient fibroblasts and controls. This suggests that any 
abnormalities in gal-l-P levels or nucleotide metabolism are 
insufficient to compromise the rate at which the cells grow 
over this timescale.
Epimerase deficient fibroblasts steadily increased in number, 
but at a slower rate than transferase deficient or control 
fibroblasts. The observation that they grow in culture is 
very important. In his description of partial epimerase 
deficiency (ie that which is detected by screening and which 
produces no clinical symptoms) Gitzelmann (1980) considers 
that complete deficiency would be incompatible with life. 
Similarly epimerase deficient CHO cells also grow at about the 
same rate as unaffected controls. This is noteworthy since 
this cell line is reported as being so galactose depleted that 
it cannot synthesise the structural protein for LDL receptors 
(Kingsley 1986). There are three possible explanations for 
the observation that epimerase deficient cells can grow in 
unsupplemented medium. These are that:
1. Some residual enzyme activity exists which is
sufficient to supply the needs of the cell for structural 
carbohydrate.
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2. Another sugar is used in place of galactose
3. The cells are able to abstract from their medium either 
galactose or an enzyme to synthesise it.
These possibilities will be discussed in the light of 
subsequent and previous experimental observations in the 
Conclusions section of this Thesis.
It is however, clear that, by whatever method or methods, the 
epimerase deficient CHO cells are able to overcome any 
constraints on their growth that their deficiency exerts. It 
must be concluded that they are not, therefore, a suitable 
model for the study of epimerase deficiency in humans.
In the experiments on protein synthesis rates, no significant 
difference was found between lines. However, in the previous 
experiment, the EDI cell line was shown to increase in number 
more slowly than the other lines. This suggests that either 
the EDI cells contain more protein that others, or that the 
protein turnover per cell is higher, for instance if 
carbohydrate formation was out of step with protein synthesis, 
leading to an increased turnover of defective glycoproteins.
Xu et al (1989a) have suggested that in vivo complications of 
galactosaemia such a premature ovarian failure are due to 
disturbed glycoprotein synthesis.
The experiments on uridine and thymidine uptake gave some very 
significant results. Uptake of both uridine and thymidine was 
significantly higher in transferase deficient fibroblasts than 
in controls or epimerase deficient fibroblasts. It is also 
clear that the relative rates of incorporation (TDl > TD2 >> 
TD3) is reproducibly common to both uridine and thymidine.
It is becoming evident that the biochemical abnormalities of
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transferase deficiency are related to disturbance of purine 
and pyrimidine metabolism. Forster (1975a) found that an 
oral galactose load caused an increase in serum urate in 
galactosaemics but none in controls, and proposed that 
depletion of nucleotides is the cause of galactosaemic liver 
damage. He also showed (1975a) that incubation of normal 
human leucocytes with galactose caused a depression of UTP,
UDP and UDP glu and accumulation of UDP gal, and that these 
effects were absent from leucocytes from galactosaemic 
patients. Pourci (1990) demonstrated that transferase 
deficient cells grown in galactose containing medium died, but 
if inosine was added to the medium, they grew normally, 
despite high levels of gal-l-P. Ng (1989) found that levels 
of UDP gal were decreased in vivo in galactosaemic red blood 
cells and in vitro in transferase deficient fibroblasts.
The results of increased uptake described in Sections 4.3.3 
and 4.3.4 could be attributed to greater rates of cell 
division (hence increased DNA and RNA synthesis) with an 
increased rate of cell death, since the proliferation of cells 
observed in Section 4.3.1 was the same as that of controls. 
Tedesco (1979) found that when transferase deficient cells 
were grown with galactose as their carbohydrate source their 
uptake of uridine was not significantly different from 
controls. These data are compatable with the observations that 
transferase deficient cells grown with glucose as their 
carbohydrate source take up more uridine, but the addition of 
galactose suppresses growth.
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4.4 Cell Growth in Media Supplemented with Galactose 
These experiments assessed the growth of cells in media 
supplemented with galactose at concentrations up to 5 mmol/L. 
Parameters assessed were change in cell number, rate of 
incorporation of radiolabelled leucine and amount of protein 
per well in multiwell plates, and morphology which was 
recorded photographically.
4.4.1 Cell numbers
Cells were grown in medium supplemented with 5 mmol/L 
galactose. Four wells were harvested for counting at times 0, 
3, 6 and 12 days for each cell line under investigation.
Three transferase deficient, one epimerase deficient and three 
control fibroblast lines were used, along with the CHO wild 
type and epimerase deficient clone. The mean and SD of each 
set of four observations are shown in Table 3 and the results 
plotted in figures 21 (control fibroblasts), 22 (transferase 
and epimerase deficient fibroblasts) and 23 (CHO cells).
Three types of growth curve are evident in the results of this 
experiment. Control fibroblasts and control CHO cells 
increase steadily in number throughout period of observation. 
Transferase deficient lines in contrast all show a drop in 
number between the 6th and 12th days. Lastly both epimerase 
deficient lines (fibroblast and CHO cells) show a continuous 
decline. By day 6, the CHO clone cells appeared on 
microscope examination to be reduced in size and had rounded 
up. By day 12 no CHO clone cells were alive.
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Cell Line Day 0 Day 3 Day 6 Day 12
NCI 100 (11) 109 (13) 131 (14) -
NC4 100 (14) 130 (20) 168 (21) 202 (17)
NC8 100 (3) 153 (22) 203 (40) 243 (37)
TDl 100 (7) 159 (15) 241 (28) 165 (14)
TD2 100 (5) 223 (30) 345 (120) 300 (55)
TD3 100 (13) 99 (15) 130 (10) 116 (27)
EDI 100 (21) 78 (9) 70 (12) 55 (11)
CHO wild 100 (18) 184 (24) 193 (13) 329 (92)
CHO clone 100 (22) 75 (7) 19 (16) 0
Table 3 - Change in cell numbers in galactose-enriched 
medium. Numbers normalised to time 0 - 100. Mean with 
standard deviation in brackets shown.
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Figure 21. Growth of Contro l F ibroblasts 
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Figure 21. A suspension of control cells was plated out into 20 
4cm wells and grown in medium containing 1 mmol/L galactose. After 
24hrs to allow cells to adhere five wells were trypsinised and 
counted (time 0). Further sets of five wells were counted at 2, 5 
and 12 days. The final observations on line NCI were lost because 
of infection of the culture.
Percent of i n i t i a l  ce l l  n u m b e r
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Figure 22. G rowth ot Enzyme D efic ien t 
Fibroblasts in  Galactose Enriched M e d ia
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Figure 22. The conditions described in figure 21 were used to for 
transferase and epimerase deficient lines. TD = transferase 
deficient cell lines, ED = epimerase deficient.
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Figure 23. CHO C e ll Growth in  Galactose 
Enriched M ed iu m
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Figure 23. Both CHO cell lines were grown in galactose enriched 
medium as described in figure 21. Mean and standard error shown.
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4.4.2 Leucine incorporation in Galactose Medium.
These experiments were similar to the leucine incorporation 
assessments carried out in normal medium, except that medium 
containing 0, 0.5, 1, 2.5 or 5 mmol/L of galactose was used. 
The mean and SD of each set of four observations and the total 
amount of cellular protein measured in each well are plotted 
in figures 24 - 30. These show two responses to increasing 
concentrations of galactose. Some lines (TDl, TD2, NC4, and 
NC5) show no change in leucine incorporation rate, while 
others (the epimerase deficient fibroblasts and lines TD3 and 
NCI) show decreases at higher galactose concentrations.
4.4.3 Photography of Effect of Galactose on Epimerase 
Deficient Cells.
Cells were grown in medium with 1 mmol/L galactose for 10 
days. Photographs taken at 10 days are shown in figures 
31-37. These show some areas of normal growth with healthy 
looking cells adhering to the flask surface plus an 
appropriately small number of cells rounded up as would be 
found in any growing population of cells. Other areas show a 
large proportion of cells rounded, cells with a granular 
appearance, very ragged clumps and areas where cells have died 
and floated off leaving a clear surface.
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Figure 24. Leucine In c o rp o ra t io n  Rate in M e d ia  
w i th  Galactose: C ontro l  F ibroblasts
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Figure 25. Protein per Well in  M e d ia  w i th  
Galactose: Contro l F ibroblasts
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A suspension of control fibroblast lines was plated out into 25 4cm wells 
of a multiwell plate. In five wells galactose free medium was used, and 
in four other groups of five wells medium supplemented with 0.5, 1, 2.5 or 
5 mmol/L galactose was added. In addition the medium added to 4 of each 
set of 5 wells contained 1 yCi/ml of H leucine, the remaining well being 
designated a blank. After 6hrs the amount of radioactivity incorporated 
and the level of protein remaining in each well were assessed and the 
incorporation rate per unit protein calculated.
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F ig u re  26. L e u c in e  I n c o r p o r a t i o n  Rate in  M e d i a  w i t h
Galactose: Transferase D e f ic ie n t  f i b r o b la s t  l i n e  TD1
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Figure 26. The leucine incorporation rate as a function of
galactose concentration was assessed for line TD1 as described in
figures 24 and 25.
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F ig u re  27. L e u c in e  I n c o r p o r a t i o n  a n d  P ro te in  p e r  W e l l  in
M e d ia  w i t h  Galactose: T ransferase  D e f ic ie n t  L in e  TD2
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Figure 27. The leucine incorporation rate as a function of
galactose concentration was assessed for line TD2 as described in
figures 24 and 25.
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F ig u re  28. L e u c in e  I n c o r p o r a t i o n  a n d  P ro te in  p e r  W e l l  in
M e d ia  w i t h  Galactose: Transferase  D e f ic ie n t  L in e  TD3
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Figure 28. The leucine incorporation rate as a function of
galactose concentration was assessed for line TD3 as described in
figures 24 and 25.
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Figure 29. Leucine In c o rp o ra t io n  in M e d ia  w i th  
Galactose: Epimerase D e l ic ien t  L ine EDI
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Figure 30. Protein per Well in  M e d ia  w i th  Galactose: 
Epimerase Def ic ien t  L ine EDI
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Figure 29 & 30. The leucine incorporation rate as a function of
galactose concentration was assessed for line EDI as described in
figures 24 and 25.
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Figure 31. Epimerase deficient fibroblasts were grown in medium 
supplemented with 1 mmol/L of galactose. After 10 days a wide range 
of microscopic appearances was observed. In this section cells 
appeared identical to control cells, with good adhesion and a small 
proportion of cells rounded up as occurs in normal division.
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Figure 32. Another section of the monolayer also has a normal 
appearance.
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Figure 33. This section shows an abnormally high number of cells 
rounded up, demonstrating a toxic effect resulting in failure of 
adhesion. The rounded cells also have an abnormal granular 
appearance.
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Figure 34. This shows an area of fairly healthy looking confluent 
cells graduating into a patch of ragged, unhealthy looking cells. 
They appear irregular and shrunken, and are not adhering, but have 
not rounded up.
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Figure 35. This shows an area where most of a population of healthy 
cells have been lost and many of the remaining are irregular and 
mis-shapen. A large number of particles of cellular debris are 
evident.
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Figure 36. Some patches of cells became abnormally thin and spindly 
without acquiring a granular or ragged appearance.
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Figure 37. In places most cells had died leaving behind a few 
grossly abnormal remnants.
4.4.4 Growth in Galactose Media - Discussion 
This section investigates the growth of cells in media 
supplemented with galactose. Some reports have been published 
of the effects of such media on transferase deficient cells, 
but none on epimerase deficient lines. Galactose is known be 
toxic to transferase deficient lines, but there are 
differences in the literature over the severity and rapidity 
of this effect. All authors used either 5 or 5.5 mmol/L 
galactose. Krooth (1960) found that cells grew until the 6th 
day then the population levelled off or decreased slightly, 
and Tedesco (1979) observed that cells exhibited noticeable 
changes at 1 week, deterioration over 1 to 2 weeks and 
irreversible damage after 2 to 3 weeks, but does not 
quantitate these observations. In contrast Pourci (1990) 
found that under very similar conditions cells stopped growing 
in 2 days and were all dead by 7.
The observations on cell numbers in galactose enriched media 
(figures 21, 22 and 23) show three types of curve, with every 
cell line of a given type rigorously following the same curve. 
All control cell lines show a steady increase with time.
This confirms the observations of the above authors that 
galactose is capable of acting as an energy source for control 
cells.
All transferase deficient lines have increased in number by 
day 6 but all decrease between days 6 and 12. These results 
are therefore in agreement with those of Tedesco and Krooth 
described above, and in contradiction with those of Pourci.
It is difficult to reconcile this differance unless it is a 
result of a disparity in culture conditions or materials not
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described by Pourci. Contamination of the galactose used by 
Pourci is unlikely, since control fibroblasts grew in the 
medium.
The third type of curve evident is a steady decline, shown by 
both epimerase deficient lines, that for CHO cells being 
particularly marked in comparison to controls (fig. 23).
Thus there is a difference between the cytotoxic effects on 
epimerase and transferase deficient lines. It was formerly 
considered that gal-l-P was the cytotoxic agent (eg Gitzelmann 
1980) but Pourci found that addition of inosine to the culture 
medium protects transferase deficient cells from the effects 
of galactose, despite high levels of gal-l-P. in 
erythrocytes, the levels of UDP gal are raised in epimerase 
deficiency (Henderson 1983) and lowered in transferase 
deficiency (Ng 1967, Xu 2989b). The very different results 
for TD and ED cell lines in figure 22 suggest that different 
cytoxic processes are affecting the two cell types, possibly 
the alteration of UDP gal levels in opposite directions 
mentioned above.
The next series of experiments measured leucine incorporation 
as a function of galactose concentration. Cells were plated 
out at approximately similar multiplicates for any one line, 
so the total amount of protein per well is also represented in 
the results, otherwise if most cells died but the remainder 
were incorporating protein at a normal rate no abnormality 
would be apparent in the leucine incorporation results. In 
some results, the protein per well is highly variable (for 
instance, note the large error bars in figures 26 and 27). 
However, the leucine incorporation rates which were calculated
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from these results have smaller error bars, suggesting that 
this is not an analytical error, but that replicates in 
plating out were variable, and that once results were 
normalised for protein, errors were acceptable. Possible 
causes include sedimentation of the cell suspension used for 
plating out, or formation of clumps of cells.
Figures 24 and 25 show that control fibroblasts were 
unaffected by concentrations of galactose up to 5 mmol/L, as 
would be expected from the results in section 4.4.1. Of the 
transferase deficient lines two showed no change and one a 
significant decrease in leucine incorporation and amount of 
protein per well. It may seem surprising that lines TDl and 
TD2 were unaffected, but they were exposed to galactose for 6 
hrs, and in section 4.4.1 it was shown that full toxic effects 
are not exhibited until after seven days of exposure. Cell 
line TD3 decreased its rate of l&ucine incorporation by 12% 
when the galactose concentration was increased from zero to 
5mmol/l, showing that this cell line is more sensitive to the 
toxic effects of galactose over this time period.
The line EDI also showed a significant drop in both parameters 
measured. Kalkar (1965) hypothesised that a completely 
epimerase deficient organism would be a galactose auxotroph, 
ie, it would require supplementation with exogenous galactose 
for normal growth. The cell line EDI did have reduced growth 
in normal medium. If Kalkar's hypothesis applied to the line 
EDI it is possible that supplementation with small amount of 
galactose in vitro (and by extension in vivo) would result in 
improved growth, whereas higher amounts would induce toxic 
effects from an accumulation of metabolites. Only the latter
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effect is evident. Thus either galactose is only toxic to 
these cells, or the level of supplementation required for 
benefit is so low as to be unobservable in these experiments. 
Various authors have published photographs of the effect of 
galactose on transferase deficient cells (eg Miller 1968, 
Pourci 1990) but none have illustrated the effect on epimerase 
deficient cells. Figures 31 to 37 show a number of abnormal 
features. These include a high proportion of cells rounded 
up, too high to represent normal levels of division, and 
unnatural granular appearance of the cells, a large amount of 
cellular debris from dead cells, vaculolation and loss of 
adhesion. These effects are similar to those described in 
transferase deficient cells but this is not evidence for a 
common mechanism since such effects are a final common pathway 
to a large number of cytotoxic processes.
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4.5 Galactose in Cells.
These experiments assessed the galactose content of cultured 
cells in order to establish whether cells with abnormalities 
of galactose metabolism also have different amounts of 
galactose incorporated in the cells. Three techniques were 
used: gas chromatography of monosaccharides in whole cell 
preparations, Western blots of cell membrane preparations with 
a galactose specific detection system, and a series of 
experiments with ricin lectin attached to fluorescein 
isothiocyanate; this was bound to cell membranes and the 
resulting fluorecence was photographed and quantitated.
4.5.1 Gas Chromatography.
Hydrolysis of cell glycoproteins and gas chromatography of the 
resultant monosaccharides gave good reliable separation and 
allowed identification of the following sugars: mannose,
galactose, glucose, ribose, N-acetyl glucosamine, N-acetyl 
galactosamine and sialic acid. Peak areas were assessed by 
the integration function of the gas chromatograph data 
handler. A sample trace is shown in figure 38.
The results of these analyses, expressed as nanomoles 
carbohydrate per milligram protein, are shown in Table 4.
The duplicate figures for each cell line represent duplicates 
of the entire procedure of cell culture, cell preparation and 
lyophilisation, protein analysis and gas
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Cell line Man Gal Glc GlcNac GalNAC SA Ribose
NC6 0.71 0.76 13.9 0.53 — 0.29 0.82
0.65 0.70 13.5 — — 0.40 0.70
NC8 1.3 0.66 14 — — 0.16 1.2
0.92 0.83 12.8 1.2 0.33 0.42 0.92
NC9 1.1 1.2 10.5 0.85 0.71 0.57 1.4
0.87 1.2 8.0 0.63 0.63 0.44 1.1
NC10 0.66 0.66 11.0 0.50 0.50 0.34 0.47
0.61 0.65 11.0 0.58 0.19 0.32 0.39
EDI 0.67 0.55 3.1 0.50 0.39 0.12 0.83
0.61 0.55 14.3 0.39 — 0.28 0.50
TDl 0.50 0.38 3.0 0.23 — 0.15 0.35
0.59 0.41 3.4 0.27 — 0.14 0.45
TD2 1.6 1.22 15.00 — — 0.78 0.89
0.82 0.72 8.1 0.36 0.27 0.18 0.36
TD3 0.66 0.46 4.7 0.32 — 0.24 0.51
0.58 0.39 4.3 0.29 — 0.18 0.47
CHO 0.50 0.25 0.25 — — — 0.44
wild 0.60 0.20 0.13 — — 0.06 0.46
CHO 0.59 0.36 1.20 — — 0.27 0.64
clone 0.58 0.33 0.37 __ __ 0.12 0.83
Table 4 Nanomoles of carbohydrate per milligram protein 
in hydrolysed cell preparations. Duplicate measurements 
made. Man - mannose Gal - galactose Glc - glucose 
GlcNAC * N-acetyl glucosamine GalNAC - 
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WOHCFILE 10= B
Figure 38. Gas chromatography of cell lysates. Lyophilised 
cell preparations were hydrolysed with methanolic HCl then 
silylated. The product was analysed by gas chromatography on 
an SE-30 column ramped between 140 and 200°C at 0.5°C/minute. 
Peaks resolved included 1 ribose, 2 mannose, 3,4,5, 
galactose, 6,7 glucose, 8 mannitol, 9 N-acetyl glucosamine 
and 10 sialic acid.
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chromatographic analysis, not merely double analysis of 
one derivitised sample. The results for all normal 
control lines were combined and the means and standard 
deviation calculated. This was repeated for transferase 
deficient lines. The resultant values were subjected to 
Student's T-Test. These are shown in Table 5.
Galactose(>c/g) Sialic acid+galactose Galactose 
protein(/yg) Mannose (/yg) Mannose(ywg)
Control 0.83 ± 0.21 1.46 ± 0.37 1.00 ± 0.22
(n-8)
Transferase
deficient 0.60 + 0.32 1.00 + 0.13* 0.77 +0.08*
(n-6)
Table 5. Carbohydrate composition of cells. * Means of 
transferase deficient and control lines significantly 
different (P <0.05)
4.5.2 Western Blots of Cell Membrane Preparations.
After electrophoresis in a polyacrylamide gel proteins were 
transfered to nitrate paper. The gel was then stained with 
Coumassie Brilliant Blue dye to allow assessment of the 
protein electrophoresis. A photograph of a gel is shown in 
figures 39. This shows good protein separation (i.e. correct 
gel preparation), progress of the protein front almost to the 
bottom of the gel (i.e. appropriate running time), good linear 
protein travel and proteins distributed fully across each
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track (i.e. no air bubbles trapped in sample wells or at the 
bottom of the gel).
The nitrate papers were also photographed at the end of the 
blotting procedure. The molecular weight marker strip was 
stained with Coumassie Brilliant Blue and the remaining strips 
with the galactose specific lectin based stain for test strips 
and this stain plus galactose for controls.
A photograph of a blotted nitrate paper is shown in figure 40. 
Normal control fibroblasts show a large number of discrete 
bands on top of an increased background stain when compared to 
controls. Epimerase deficient fibroblasts show an identical 
pattern of bands and background stain, but at a lower density. 
This shows that epimerase deficient fibroblasts grown under 
the conditions described have galactose-containing 
glycoproteins in their cell membranes.
For the wild type Chinese Hamster Ovary cells stained bands 
are also evident over the same molecular weight range as for 
fibroblasts but with a different pattern. Epimerase deficient 
CHO cells show a very different pattern. The first (i.e. 
highest molecular weight) band of the wild type cells is 
clearly present to a similar degree but the subsequent banded 
pattern is completely absent. There is a general increase in 
background staining, although to a lower extent than with the 
wild type cells.
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Figure 39. Western Blot stage Is electrophoresis.
Solubilised cell preparations were subjected to electrophoresis in 
an 8% SDS-polyacrylamide gel. After electrotransfer to cellulose 
nitrate paper the gel was stained with Coumassie Brilliant blue, 
dried and photographed.
Figure 40. Western Blot stage 2: solublised cell preparations were 
electrophoresed on SDS-polyacrylamide gel, blotted onto cellulose 
acetate paper and detected with a galactose specific lectin 
preparation. 1: normal red cell ghosts, 2: normal control 
fibroblasts, 3: normal control fibroblasts, 4: epimerase deficient 
CHO cells, 5: wild CHO cells, 6: epimerase deficient fibroblasts, 7 
normal control fibroblasts.
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4.5.3 Examination and Photography of cells stained with FITC 
linked lectin.
Slides were initially examined under phase-contrast and 
visible light illumination. This showed adequate cell 
densities on all slides. Cell integrity was assessed by 
examining for trypan blue staining. On all slides the vast 
majority of cells were not heavily stained, showing that the 
staining procedure had not visibly damaged the cells. 
Examination of test slides under ultra-violet illumination 
showed diffuse green fluorescence restricted to cells.
Control slides (those where galactose was added to the stain) 
showed no fluorescence. Results of the examination are 































CHO wild test fluorescence
control no fluorescence
CHO clone test very low fluorescence
(ordinary medium) control no fluorescence
CHO clone test low fluorescence
(dialysed medium) control no fluorescence
Table 6. Staining of cells with FITC linked lectin
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Figure 41 to 48. Cells were grown on sterile glass coverslips then 
stained either with fluoroscein linked lectin solution (tests) or 
fluoroscein linked lectin solution plus galactose (controls). The 
stained slides were examined microscopically and photographed under 
phase contrast illumination, ultra-violet light, or a combination of 
the two. On this page figs. 41 and 42: normal control cell line NCI 
under combined and UV illumination.
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Figure 43. An area of control cell line NC4 under phase contrast
and UV illumination.
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Figure 44. An area of transferase deficient cell line TD1 under
phase contrast and UV illumination.
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Figure 45. An area of epimerase deficient fibroblast line EDI under
phase contrast and UV illumination.
Figure 46. An area of epimerase deficient fibroblast line EDI 
under phase contrast and combined UV and phase contract 
illumination.
Figure 47. An area of wild type CHO cells under phase contrast and 
UV illumination.
Figure 48. An area of epimerase deficient CHO cells under phase 
contrast and UV illumination.
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In particular, the epimerase deficient fibroblasts appeared 
to stain in a similar manner to normal control fibroblasts.
In contrast, epimerase deficient CHO cells appeared to stain 
significantly less brightly than wild type CHO cells.
Figures 41-48 show photographs of cells under phase contrast 
and UV illumination. Representative examples are shown of 
two normal control, one transferase deficient and the 
epimerase deficient fibroblast lines, and both CHO cell 
lines.
4.5.4 Quantitation of Fluorescence.
This method was validated by examining the relation between 
the amount of fluorescence measured and three other 
variables: the number of cells present, the amount of protein 
present, and the amount of fluorescently labelled lectin 
added.
Figure 49 shows the amount of fluorescence measured against 
the cell count for a control fibroblast line and figure 50 
for a CHO line. A linear relationship is evident from both 
graphs.
Figure 51 and 52 show fluorescence against the amount of 
protein present for control fibroblast and CHO cell lines. 
Once again a linear relationship is evident.
Figures 53 and 54 show fluorescence per unit protein as a 
function of lectin concentration for two control fibroblast 
lines, and figure 55 for a CHO line. The fibroblasts show an 
initial positive slope, which levels out suggesting that if 
at least 1 ml of lectin solution is added per well then the
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amount of fluorescence detected is independant of the amount 
of lectin added.
The conditions derived as a result of the above experiments 
were used to quantitate the amount of fluorescence per unit 
protein for a number of cell lines.
These are shown in Table 7.
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Figure 49. F luorescence versus Ce ll 
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Figure 49. Fibroblasts were grown to a range of densities in 
multiwell plates. Wells were washed and one ml of a FITC solution 
(20 micrograms lectin protein per ml) in PBS was added and plates 
incubated for 30 mins. Wells were washed, cells trypsinised and 
counted, then dissolved in 1 ml of 0.1M NaOH and the fluorescence 
determined in a Shimadzu fluorimeter.
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Figure 50. Fluorescence versus C ell 
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Figure 50. The experiment described in figure 49 was repeated for 
CHO cells.
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Figure 51. Fibroblasts from control line were grown to a range of 
densities in multiwell plates and stained with FITC lectin as 
described in figure 49. Wells were washed with PBS and the cell 
layer dissolved in 0.1M NaOH. Of this 400 pi were used for protein 
estimation by the Coumassie Brilliant Blue method and the remainder 
for quantitation of fluorescence.
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Figure 52. The experiment described in figure 51 was repeated using 
CHO cells.
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Figure 53. Fluorescence per Unit Protein 
versus Amount ol Lectin - Norm al 
Control Fibroblast Line NC8
Figure 54. Fluorescence per Unit Protein 
versus Amount oi Lectin -  Norm al 
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Figure 55. Fluorescence per Unit Protein 
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Cells from lines NC8, NC14 6 ’grown in multiwell plates to a range
of densities. Various amounts (0.2 to 1.5 mis) of a solution of FITC lectin in 
PBS (20 yg lectin protein per ml) were added to the wells and plates incubated 
for 30 mins. Wells washed copiously and cell layer dissolved in 0.1 M NaOH.
This was used for estimation of protein and quantitation of fluorescence.
Results were plotted as fluorescence per unit protein vs. amount of lectin added 
to show whether the level of binding was dependent on the amount of lectin added.
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Cell line Fluorescence/protein n SD
NC2 0.52 8 0.06
NC9 1.70 6 0.18
NC10 0.83 7 0.15
EDI 0.81 8 0.10
TDl 1.48 8 0.35
TD2 1.46 6 0.31
TD3 1.33 6 0.30
CHO clone 0.64 12 0.11
CHO wild 0.80 10 0.16
Table 7. Fluorescence per unit protein. This quantitates the 
binding of fluorescein linked ricin lectin by intact cells, 
n - number of samples tested. SD * standard deviation.
4.5.5 Carbon-14 CO2 from labelled Galactose.
Initial experiments were carried out with the CHO cell lines. 
The results are shown in Table 8 and graphically in figure 56. 
The incubation period in this experiment was 24 hrs.
\









Figure 56. P roduction ol R a d io la b e lle d  








Erlenmyer flasks were prepared containing sub-confluent monolayers of CHO wild 
and clone cells. A paper disc soaked in concentrated NaOH was placed in the cap 
and the medium replaced with one supplemented with 0.1 pCi/ml of carbon-14 
labelled galactose. Flasks were incubated for 6 hrs after which the carbon-14 
CO^ produced was estimated by beta-counting the discs in 2 mis of cocktail T 
scintillant, and the protein per flasks measured by the method of Folin and 
Ciocalteau. Three observations are shown with bar height equal to the mean.
A c t iv i t y  ( c p m /m g  pro te in)
W ild
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These results show a level of activity 7.2 times greater in 
wild type cells, but they also show a significant and 
reproducible level of activity in the CHO clone cell line.
The maximum percentage conversion of the labelled substrate 
was 0.3% for CHO wild cells and 0.025% for CHO clone cells. 
This experiment was also attempted with three normal control 
fibroblast lines. The maximum percentage conversion obtained 
with fibroblasts was 0.025% of total activity.
4.5.6 Section 5: Galactose in Cells: Discussion
All previous work on the abnormalities in human cells with 
disorders of galactose metabolism had concentrated on 
measuring levels of metabolites, rates of CO2 production or 
levels of incorporation from labelled galactose (Xu 1989a, 
Kaufmann 1989) rather than assessing the levels and structures 
of the end points of incorporation such as glycoproteins, as 
is examined in this section.
Similar work had previously been carried out on epimerase 
deficient salmonella (Nikaido 1960 Fukosawa 1960). These were 
found to contain no galactose in their cell walls. It was not 
known whether this occurred in human or CHO cell lines. Xu
(1989a) showed that incorporation of labelled galactose into
TCA insoluble material was reduced in transferase deficient 
cell lines and hypothesised that some of the complications of 
galactosaemia are due to interference with the synthesis of 
galactose containing glycoproteins and glycolipids.
The experiments on the gas chromatography of carbohydrates 
from hydrolysed cells answers some of these questions.
Firstly, both epimerase deficient lines contained galactose,
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and in amounts not significantly different from controls.
Thus they do not substitute glucose in the manner of epimerase 
deficient salmonellae.
Secondly, transferase deficient cells contain significantly 
lower levels of the ratio of galactose to mannose, and of 
sialic acid plus galactose to mannose than control 
fibroblasts. Sialic acid is found as a terminal residue on 
galactosyl chains. It had formerly been assumed that in the 
absence of transferase, the alternative pathway from 
glucose-l-phosphate via epimerase could maintain sufficient 
UDP gal for the synthesis of glycoproteins. The demonstration 
of low UDP gal levels in galactosaemic patients together with 
these results suggest that a disorder of galactosylation might 
play a part in the pathogenisis of galactosaemia, particularly 
in the long term complications of this condition. The ovary 
is a tissue particularly rich in galactose containing 
glycoproteins (Kaufmann 1988) and the profound ovarian 
dysfunction seen in female galactosaemics would appear to 
conform to this hypothesis. These results have been published 
(Dobbie 1990).
The results of the Western blot confirm the above observations 
that epimerase deficient cells contain galactose, using a 
completely different experimental technique and detection 
system. Cell line EDI shows a similar pattern to controls 
suggesting that glycoprotein structures are not disordered, 
but at a slightly reduced density. This is in accord with the 
GC results which showed a lower total galactose level in line 
EDI. Transferase deficient cells also appear similar to 
controls; it therefore seems likely that the reduction found
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by gas chromatography is spread across a wide range of 
glycoproteins. In the CHO lines, the epimerase deficient 
clone shows a different pattern from the control line, and as 
with fibroblasts the total galactose level by GC was lower in 
the clone. It is possible that this disordered pattern could 
be a result of the epimerase deficiency in the CHO cell lines 
being more severe than in the fibroblast line.
The observation and photography of FITC-linked lectin once 
again confirmed the presence of galactose on the cell 
membranes of all cell lines studied. The diffuse staining all 
over the cell surface is typical of specific lectin binding 
(Brachet 1985) and was completely suppressed in all cases by 
the addition of galactose. Because some subjective 
differences in the degree of staining were observed, a method 
of quantitating the degree of fluorescence was devised.
This consisted of solubilising the cells and measuring the 
degree of fluorescence. Trypsin has been shown to alter the 
number of lectin receptors on cell surfaces (Sharon 1975) so 
it was not used in these experiments, except for the 
validation that fluorescence was a function of cell number 
where its use was unavoidable. Fluorescence was shown to be 
linearly related to cell number for fibroblasts and CHO cells 
(figures 49 and 50) and protein (figures 51 and 52), and 
unrelated to the volume of lectin added above 1 ml. The 
results of quantitation show that binding to the CHO clone is 
significantly lower than the wild type, and that transferase 
deficient fibroblasts are significantly lower than controls. 
These observations confirm the results found by gas 
chromatography.
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The final experiments in this section concerned the oxidation 
of radiolabelled galactose to C02 . Experiments on the CHO 
lines (table 8) showed a seven-fold difference in the rates of 
CO2 production. There was however, a small but significant 
rate of oxidation by the CHO clone which has been described as 
having zero epimerase activity (Kingsley 1986). The 
production detected could result from residual enzyme 
activity, metabolisable impurities in the radio-label (eg 
labelled glucose) or metabolism via alternative pathways which 
have been shown to exist (Cuatrecasas 1966). It was therefore 
concluded that this was not an experimental technique whereby 
low levels of activity in the epimerase deficient fibroblast 
line could be detected.
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4,6 Conclusions and Further Work
4.6.1 Conclusions 
Cell Culture
It is possible to prepare media which contains no measurable free 
galactose. The amount of any free galactose which is present can 
be further reduced by dialysis and the resulting medium can be 
used to culture cells reliably.
The presence of combined galactose in foetal calf serum proteins 
was confirmed. Galactoproteins with exposed galactosyl residues 
may be partially removed with a solid phase linked lectin column. 
Since glycoproteins which contain unexposed galactosyl residues 
will not be removed by this technique it is not suitable for 
preparing a medium free of any combined galactose.
Transferase Deficient Cell Lines
By all the parameters assessed, transferase deficient cells will 
grow in normal growth medium at a rate similar to control lines 
over the time scale investigated.
The most significant finding in this work is that transferase 
deficient cells grown in normal media have a different balance of 
carbohydrates in their glycoproteins. In particular, galactose is 
significantly reduced. It has always previously been assumed that 
in the absence of transferase adequate levels of UDPgal could be 
maintained by its synthesis from glucose-l-phosphate. The 
demonstration in this work of abberant glycosylation in vitro 
suggests that the formation of defective glycoproteins in vivo may 
play a part in the pathogenesis of galactosaemia, particularly the
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long-term complications of the condition. Abnormally glycosylated 
glycoproteins have now been found in vivo by Spaapen et al (1992). 
Two untreated female galactosaemic infants had transferrins in 
their sera which showed a pattern on isoelectric focusing 
suggestive of reduced glycosylation. This result supports the 
conclusions of this thesis and confirms its implications for 
metabolism in vivo.
Abnormal nucleotide metabolism in transferase deficient cells was 
confirmed in the experiments showing raised uptake of uridine and 
thymidine.
Recent work by Berry (1992) has shown that in vivo, galactosaemics 
have an increased ratio of UDP glucose to UDP glacatose compared 
with controls but they attribute this to dietary restriction of 
galactose, since a smaller increase in the ratio was also observed 
in subjects with other inherited disorders who were on 
milk-restricted diets. These observations are compatable with the 
results in this thesis, since the cells in which reduced amounts 
of galactosylation were found were grown in medium with no 
measurable galactose, i.e. they were on a "galactose free diet".
Epimerase Deficient Cell Lines
Epimerase deficiency had previously been considered likely to be a 
lethal mutation. However, both epimerase deficient fibroblasts 
and CHO cells were observed to grow in culture. There are three 
possible explanations for this:
1) The alternative sugar: epimerase deficient salmonellae 
substitute glucose for galactose in their cell wall glycoproteins: 
possibly CHO cells and fibroblasts do the same. It may be thought 
surprising that even a simple prokaryote can remain viable after
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such a significant change: the much more sophisticated mammalian 
cells relies even more heavily on the exact stereochemistry of 
their constituent molecules. It is therefore theoretically 
unlikely that this can be an explanation for the growth of 
epimerase deficient cells. This hypothesis was experimentally 
disproved by the detection of significant amounts of galactose in 
the walls of both these cell lines.
2) Abstraction: cells incapable of synthesising galactose may 
abstract it from their growth medium, or they may conceivably 
abstract an enzyme capable of synthesising it. One of the objects 
of these experiments was to prepare a culture medium as low in 
galactose as possible. Whilst uncombined galactose was virtually 
eliminated, it was not feasible to produce a medium free of 
combined galactose. The required enzyme was not detected in the 
culture medium. Since the epimerase deficient salmonellae were 
not able to acquire sufficient galactose from their media it seems 
unlikely that fibroblasts or CHO cells could. However, it is not 
possible to rigorously exclude this explanation.
3) Residual Activity: Possibly these epimerase deficient cells
grow because they are not truly epimerase deficient. It is 
impossible to prove that no activity exists in these cells, only 
that there is less than can be measured experimentally.
Indeed many inherited enzyme deficiencies are caused by the 
production of a protein with a single amino acid substitution, 
usually in the active site. In transferase deficiency a protein 
immunologically identical to the missing enzyme but without 
measurable activity is produced. It is thus reasonable to
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hypothesise that epimerase deficient cells grow because an altered 
enzyme is synthesised which has too little activity to be 
measured, sufficient to supply the cell with galactose for its 
structural requirements, but not enough to break down a galactose 
load, leaving the cells vulnerable to galactose toxicity.
It is therefore not possible to distinguish between possibilities 
2 and 3, i.e. residual activity or abstraction from a low 
galactose environment on the basis of the experimental results 
contained in this work.
However, since Gillett (1985) found 11% of control levels of 
epimerase activity in a liver biopsy from the same index case that 
provided the fibroblast line, it is likely that in vivo at least 
residual activity is present in sufficient levels to provide 
adequate galactose for structural requirements.
The most important implications of this work are those for the 
treatment of epimerase deficiency in vivo. Although it is not 
possible to say precisely why, it is clear from the various 
assessments of cell growth that epimerase deficient cells grew 
adequately without any galactose supplementation but where a small 
amount of combined galactose was available. Sources of galactose- 
containing glycoproteins similar to those in foetal calf serum 
exists in meat and vegetable proteins in the human diet. It was 
also observed that epimerase deficient cells grew no better when 
supplemented with galactose.
All this suggests that the need for galactose supplementation in 
vivo for epimerase deficient subjects must be questioned.
However, before therapeutic recommendations are made it is vital 
to remember the limitations of the cultured cell as a model; the 
conclusions above apply to fibroblasts. Other classes of cells
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such as neurones and oocytes are richer in galactoproteins; the 
effect on these cell types of the absence of galactose 
supplementation is not known.
A final implication of this work concerns the papers from the 
laboratory of Krieger (e.g. Kingsley DM and Krieger M and Holton 
JB 1986; Kingsley DM, Kozarshy KF, Hobbie L and Krieger M 1986).
In these the authors describe how an amphotericin containing 
medium selects a population of CHO cells which are deficient in 
low density lypoprotein (LDL) receptors, which may be used as a 
model for familial hypercholesterolaemia. These cells were found 
to be epimerase deficient, and in fact were the CHO clone used in 
this work. Krieger states "complete deficiency of epimerase.. 
disrupts the synthesis of many glycoproteins and glycolipids. As 
a consequence, the hamster cells synthesise abnormal forms of the 
LDL receptor, a glycoprotein". The results described in this 
thesis show by three different analytical techniques that 
galactose is present in significant quantities in the cell walls 
of this clone of CHO cells when grown as described. Krieger 
(1983) states that high concentrations of serum may restore LDL 
receptor activity but gives no further details and refers only to 
"unpublished data" and gives no figure for the percentage of 
foetal calf serum used. In another paper in this series (Kingsley 
et al 1986) 5% of foetal calf serum is used, the same as in the 
experiments described here. The results in this thesis indicate 
that the lack of LDL receptors in this clone of CHO cells does not 
result from the absence of galactose, a structural component of 
these receptors.
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4.6.2 Suggestions for further work
No further experiments with radiolabelled galactose are advocated, 
either for measuring production of radiolabelled C02 or inclusion 
in acid precipitable fractions of cell homogenetics. Such 
experiments would be hampered by the limited purity of commercial 
radiolabels and metabolism by the minor pathway of galactose to 
xylulose. They are therefore likely to be uninterpretable.
Further experiments suggested by the conclusions of this work 
which are likely to produce meaningful results include the 
following:
1) If the epimerase deficient salmonella used by Nikaido (1961) 
which were found not to have galactose in their cell walls could 
be obtained they could be grown in the media used in these 
experiments and analysed for galactose. Absence of galactose 
would support the contention that there is insignificant galactose 
available in this medium.
2) Transferase deficient cells were shown to have abnormal 
glycoproteins, but in all growth experiments were found to have 
growth rates similar to control cells. This suggests that either 
the cells were not handicapped by their reduced levels of 
galactose or that the experiments were not conducted over a 
sufficiently long timescale to observe any effect. This is 
concordant with the observation that in humans, once on a 
galactose free diet galactosaemics develop in an ostensibly normal 
fashion until long term sequellae become apparent, such as 
infertility. It would therefore be appropriate to examine cells 
over a longer timescale than 7 days to see if differences in cell 
growth become apparent.
3) The implications for the therapy in vivo of epimerase 
deficiency warrant further consideration. It would be important 
to examine whether the observation that fibroblasts need no 
galactose supplementation applies to other cell types. The only 
other easily obtained culturable cell type would be lymphocytes. 
These could be subjected to the same analysis as fibroblasts. An 
alternative consideration of the problem would be to analyse 
tissue or blood samples from affected subjects. The presence of a 
normal level of galactosylation in proteins in vivo of a subject 
on a galactose free diet would provide the best possible evidence 
that galactose supplementation would be of no benefit to subjects 
affected by epimerase deficiency.
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